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Embryonic stem (ES) cells are unique in their ability to self-renew indefinitely 
and maintain pluripotency. These properties require transcription factors that form 
the unique transcriptional regulatory network to specify the gene expression 
program of ES cells. It has been possible to redirect the highly differentiated state 
of somatic cells back to a pluripotent state with a combination of four 
transcription factors: Klf4 is one of the reprogramming factors required, in 
conjunction with Oct4, Sox2 and c-Myc. Maintenance of self-renewal and 
pluripotency of ES cells requires Oct4, Sox2 and c-Myc, but Klf4 is dispensable.  
 
In this project, we show that the three Krüppel-like factors: Klf2, Klf4 and Klf5, 
are required for the self-renewal of ES cells. Individual Klf is dispensable for 
maintenance of the undifferentiated state of ES cells. However, simultaneous 
depletion of Klf2, Klf4 and Klf5 by RNA interference (RNAi) leads to ES cell 
differentiation. Any of the three Klf RNAi-immune cDNAs can rescue the 
differentiation phenotype, strongly suggesting the functional redundancy among 
the three Klfs.  
 
The mechanisms of redundancy among Klf2, Klf4 and Klf5 are investigated in ES 
cells. Chromatin immunoprecipitation coupled to microarray assay (ChIP-on-chip) 
reveals the binding patterns of the three Klfs were strikingly similar and they also 
shared a significant portion of common binding loci in vivo, indicating Klf2, Klf4 
and Klf5 are collaborated to regulate common target genes. The three Klfs target 
 VI 
to enhancer region of Nanog where the Klf motif is identified. Enhance reporter 
assay coupled with motif mutagenesis and Klf RNAi show that the intact Klf 
binding motif and the three Klfs are required for the enhancer activity in ES cells.  
 
Klf2, Klf4 and Klf5 share many common targets of Nanog by comparing Klfs and 
Nanog ChIP-on-chip data, suggesting a close functional relationship between 
these factors. Expression analysis after triple RNAi of the Klfs shows that they 
regulate key pluripotency genes, such as Nanog, Esrrb, and Tcl1.  
 
Functional redundancy between Klf2, Klf4 and Klf5 is revealed by factor-induced 
reprogramming assay.  Klf2 or Klf5 is able to replace the Klf4 in generating 
reprogrammed cells together with other reprogramming factors Oct4, Sox2 and c-
Myc. Klf2 reprogrammed cells are incorporated extensively in the chimeric 
embryo, displaying pluripotency.  
 
Our study provides new insight into how the core Klf circuitry integrates into ES 
cell transcriptional network to specify gene expression program that is required 
for maintaining the pluripotent state of ES cells.  
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CHAPTER I. INTRODUCTION 
Stem cells can be identified and derived from both embryonic and adult tissues in most 
multi-cellular organisms where they are important for normal embryo development and 
cell regeneration. Two unique characteristics distinguish stem cells from other types of 
cells. First, stem cells are unspecialized cells that renew themselves for long periods by 
self-replication. Second, under certain conditions, they can be induced to become 
specialized cells with specific functions such as the dopamine (DA)-producing neurons or 
the beating heart cells. Thus they are thought to be holding great promise for regenerative 
medicine.   
 
Stem cells in mammals are mainly classified into four groups according to their 
differentiation potentials: totipotent stem cells, pluripotent stem cells, multipotent stem 
cells, and unipotent stem cells. A totipotent cell can develop into a whole organism.  
Pluripotent cells can give rise to almost all cell types of a mammal, but can not form the 
trophoblast that is necessary for the embryo to grow in uterus. A multipotent cell can 
differentiate into many, but not all of specialized cell types. Only one type of cells can be 
derived from unipotent stem cells.  
 
Mouse embryonic stem (ES) cells are pluripotent cells with various applications. For 
example, they are used as in vitro models to study mammalian developmental processes 
and cell therapy in regenerative medicine. They are widely used for making transgenic, 




mechanisms of self-renewal and pluripotency maintenance of stem cells. Moreover, huge 
amounts of work go into the exploration of their therapeutic potential.  
 
Mouse ES cells derived from inner cell mass (ICM) of blastocyst stage embryos can be 
cultured in dishes by using various combinations of feeder cells, conditioned medium, 
cytokines, growth factors, hormones and fetal calf serum. The external stimuli which play 
important roles in maintaining the ES cells in an undifferentiated state have been 
explored, such as LIF, BMP and Wnt signaling pathways. Mouse ES cell maintenance 
also require intact intrinsic transcriptional regulatory network to specify the gene 
expression program in ES cells. The core intrinsic transcription regulatory network in 
mouse and human ES cells has been revealed by genomic-wide location analysis of the 
key transcription factors: Oct4, Sox2 and Nanog. Recent studies show that external 
signaling pathways can be integrated with the core transcriptional regulatory network in 
mouse ES cells and these cells have an innate programme for self-renewal that does not 
require extrinsic instructions which highlight the critical roles of the intrinsic 
transcription regulatory network for ES cell self-renewal and pluripotency.  However, in 
despite of the progress in recent research, the detailed mechanisms of how ES cells 
maintain their unique properties are still vague.  
 
Reprogramming is a process of inducing highly differentiated cells to reverse their 
developmental potential to the pluripotent state. Somatic differentiated cells can be 
reprogrammed by somatic cell nuclear transfer (SCNT) or fusion with pluripotent stem 




in obtaining human embryonic tissues and defects of fusion cells. These successful 
reprogramming approaches demonstrate that the epigenetic state of terminally 
differentiated cell is not permanently fixed but can revert into an embryonic state that is 
capable of directing development of a new organism. It is proposed that there are some 
key factors which are able to redirect the cell fate in the oocyte or embryonic stem cells. 
Recently, a breakthrough approach shows that mouse and human somatic cells can be 
reprogrammed into a pluripotent state through retroviral introduction of four transcription 
factors: Oct4, Sox2, Klf4 and c-Myc. This new reprogramming approach sheds light on 
the clinical application of stem cells which has been impeded by lack of efficient and 

















1.1 Pluripotent stem cells   
Pluripotent stem cells can be derived from teratocarcinomas, preimplantation embryos, 
postimplantation embryos and germ cells. They are unique in their ability to undergo 
prolonged symmetrical self-renewal and maintain capacity in differentiation. In addition, 
pluripotent stem cells can also be artificially obtained through reprogramming approaches, 
such as SCNT and cell fusion. These pluripotent stem cells share similar properties, 
despite the fact that they are isolated and derived from different sources and by different 
methods.  
 
The stringent definitions of pluripotent stem cells are characterized by several factors: 
indefinite self-renewal; capacity for differentiation to specialized cells of three germ 
layers; extensive contribution to primary chimeras; and germline transmission. Most 
stringently, pluripotency can be measured using tetraploid embryo complementation: a 
standard achieved by only a limited subset of mouse ES cells1.  
 
1.1.1 Mouse embryonic carcinoma cells  
Mouse embryonic carcinoma (EC) cells are initially derived from the spontaneous 
malignant teratomas (referred to as teratocarcinomas) which contain a mixture of 
differentiated cells and undifferentiated cells in mouse testes2. Follow-up studies show 
that teratocarcinomas can be obtained from transplantation of pregastrulation stage 
embryos3-5. The origin of teratocarcinoma-forming cells within pregastrulation stage 




Mouse EC cells are able to proliferate indefinitely in vitro and form teratocarcinomas in 
nude mice. When introduced into mouse embryos, they sometimes incorporate into 
embryos and contribute to different tissues, displaying pluripotency7, 8.  Mouse EC cells 
are almost always aneupoid which prevents germline transmission9.  
 
The pilot work in mouse EC cells contributes to the derivation of the mouse ES cells. The 
supporting layer of fibroblast and the conditioned medium were found to favor the 
maintenance of the EC cell lines10.  
 
1.1.2 Mouse embryonic stem cells 
In 1981, two groups independently established ES cell lines directly from the inner cell 
mass (ICM) of mouse blastocysts11, 12. Mouse ES cells have also been derived from 
cleavage stage embryos and even from individual blastomeres of two- to eight-cell stage 
embryos13, 14. When reintroduced into mouse blastocysts, these cells were found to 
contribute extensively into different tissues and give rise to the chimeras. More 
importantly, these cells contribute to the germ lineage and transmit into the next 
generation.  
 
Mouse ES cells are unique in their ability to self-renew indefinitely and maintain the 
pluripotency. They can be induced to differentiate into diverse types of specialized cells15; 
even germ cells by embryoid body (EB)-mediated differentiation or adhesion 




generic resource for the study of cell differentiation processes. Mouse ES cells also serve 
as a promising and powerful tool for regenerative medicine.  
 
Mouse ES cell genomes can easily be modified by homologous recombination or 
insertion. The generation of knockout, knockin and transgenic mice utilizes cultured ES 
cells to target genes in vitro. These genetic modified mice are invaluable animal models 
for studying functions of genes or regulatory elements in genetic diseases and 
developmental processes19.  
  
1.1.3 Mouse embryonic germ cells and pluripotent spermatogonial stem cells  
The germ cell lineage is a specific cell population that undergoes a series of 
differentiation steps before giving rise to either eggs or sperms. Primordial germ cells 
(PGCs) are the embryonic precursors of the germ cell lineage, which are restricted to 
form only sperms or eggs following their specification from pluripotent epiblast 
cells.  PGCs can be induced to dedifferentiate or be reprogrammed into pluripotent 
embryonic germ (EG) cells in vitro when exposed to exogenous signaling molecules: LIF, 
bFGF and SCF. Mouse EG cell lines, derived from PGCs immediately before the onset of 
migration at 8.0 and 8.5 days post coitum (dpc), from germ cells migrating in the hind gut 
endoderm at 9.5 dpc, or after entry into the genital ridges at 11.5 and 12.5 dpc, have 
many properties of ES cells20, 21.  
 
Similar to ES cells, EG cells can be maintained at a self-renewal state in culture. They are 




retain the erased imprinting pattern acquired during the process of germ cell development, 
which account for the skeletal abnormalities seen in some chimeras from EG cells 
derived from germ cells at 11.5 and 12.5 dpc23, 24.  The embryos, derived by transferring 
the nuclei of 15 dpc male germ cells into enucleated mouse eggs, survive to 9.5 dpc and 
show gross growth retardation. The imprinted genes examined exhibit hypomethylation 
at all sites 25.  
 
Recently, pluripotent spermatogonial stem cells or adult germline stem cells have been 
derived from spermatogonial cells of adult mouse and human testis. These cells are able 
to differentiate into various types of specialized cells of all three germ layers when grown 
under differentiation conditions. When injected into an early blastocyst, mouse 
pluripotent spermatogonial stem cells contribute to the development of various organs 
and show germline transmission26, 27. 
 
1.1.4 Mouse EpiSCs and FAB stem cells  
Pluripotent stem cells can be derived from the late epiblast layer of post-implantation 
mouse and rat embryos by using chemically defined, activin-containing culture medium 
that is sufficient for long-term maintenance of human ES cells. These cells are referred to 
as EpiSCs (post-implantation epiblast-derived stem cells). The EpiSC lines are distinct 
from mouse ES cells in their epigenetic state and the signals controlling their 
differentiation. Furthermore, EpiSCs and human ES cells share patterns of gene 




EpiSCs fail to contribute to chimera formation when injected into recipient blastocysts28, 
29.  
 
A novel stem cell line is derived from murine blastocyst embryos in theculture conditions 
previously applied to derivation of EpiSCs from epiblast stage embryos. These cells are 
termed as FAB-SCs for bFGF, Activin, and BIO-derived stem cells. FAB-SCs express 
common molecular markers but fail to pass hallmark tests of pluripotent differentiation. 
However, FAB-SCs can be stimulated with LIF and BMP4 and induced into pluripotent 
cells30.  
 
1.1.5 Pluripotent stem cells obtained from other species 
Development of mouse ES cell lines has great impact on research fields, thus significant 
efforts have been invested in the derivation of human pluripotent stem cell lines. Three 
counterpart pluripotent cell types have been established from human tissue: human EC 
cells, human EG cells, and human ES cells31-34.  
 
Human EC cell lines are derived from the undifferentiated stem cell component of germ 
cell tumors. The EC lines can grow continuously in culture and also produce specialized 
cells of all three germ layers in vitro or different tissues through teratoma formation. The 
EC cells are usually aneuploid and carrying an abnormal karyotype35, thus prevent them 
from medical applications. Human EG lines are derived from primordial germ cells in the 
genital ridges of the developing embryos, typically at 5 to 11 weeks after fertilization in 




Human ES cells are derived from inner cell mass (ICM) of human blastocysts. They can 
be maintained in culture under special conditions, and form derivatives of all three germ 
layers. However, human ES cells are different from mouse ES cells in many aspects.  
Human ES cells require the supplement of basic fibroblast growth factor (bFGF) and 
transforming growth factor b (TGFb)/activin36. Mouse ES cells remain undifferentiated in 
the presence of leukemia inhibitory factor (LIF) and bone morphogenetic protein 
(BMP)37. The colony morphology of human ES cells is different from that of mouse ES 
cells. The former cells form flat, sheet-like colonies, while the latter cells form round and 
island-like ones. Human ES cells grow slower than mouse ES cells and are able to be 
induced into trophectoderm linage cells while mouse ES cells normally can not38, 39.  
Human ES cells share some, but have distinct gene expression profiles and regulatory 
networks compared to mouse ES cells40.  
 
Rat models have phenotypic characteristics that are relevant to particular human 
conditions41. However, traditional methods fail to derive authentic rat ES cells with 
stringent characteristics of pluripotent stem cells42, 43. Recently, Rat ES cells have been 
efficiently derived in the presence of chemical compounds that specifically inhibit GSK3, 
MEK, and FGF receptor tyrosine kinases. These rat ES cells fulfill all the stringent 
criteria for the definition of pluripotent stem cells44, 45.  Most importantly, germline 
transmittable rat ES cells will be a useful tool to manipulate the rat genome.  
 




Pluripotent stem cells can also be artificially obtained from reprogramming approaches, 
such as SCNT, cell fusion or introduction of reprogramming factors. It has long been 
believed that developmental processes and differentiation are in one direction and 
irreversible for animals. This view is debated by studies which show that the enucleated 
frog eggs are able to develop into normal swimming tadpoles and frogs when 
transplanted nuclei from differentiated frog cells 46-48. These results conclude that the 
process of cell differentiation can be fully reversed. The next major breakthrough in this 
field came with the production of an adult sheep (Dolly) by transferring the nuclei of 
cultured mammary gland cells derived from an adult sheep to enucleated sheep eggs49. 
Later on, SCNT or nuclear reprogramming has been successfully achieved in different 
mammalian species, suggesting that this procedure might work with humans50. SCNT or 
nuclear reprogramming has been shown to produce mouse or rhesus macaque blastocysts 
from fully differentiated cells and successfully isolate ES cell lines from them50, 51.  
 
Pluripotent ES cells such as EC cells, ES cells, and EG cells have a unique property of 
being able to carry out nuclear reprogramming of somatic nuclei, as shown after cell 
fusion52-54.  The resultant hybrid cells are tetraploid and exhibit characteristics of normal 
pluripotent cells, including apparent immortality in culture and colony morphology. The 
pluripotency of the hybrid cells fused with mouse ES cells and somatic cells is 






A surprising advance in this field comes when it is discovered that viral transfection of 
four genes (Oct4, Sox2, c-Myc, and Klf4) into mouse embryonic or adult fibroblast cells 
lead to the appearance of some cells displaying ES cell characteristics56.  These cells are 
referred to as induced pluripotent stem (iPS) cells and have been tested by all the 
pluripotency criteria57, 58, demonstrating iPS cells are authentic pluripotent stem cells.  
 
1.2 Extrinsic factors required for mouse ES cells  
Mouse ES and MEF cells are used to elucidate the mechanisms of ES cell self-renewal, 
pluripotency and somatic cell reprogramming in this study. Mouse ES cells have many 
advantages over other types of stem cells as they are the first established authentic 
pluripotent cells which have been widely used as models both in vitro and in vivo. The 
pluripotency of reprogrammed cells can be validated by the different kinds of assays 
established for mouse ES cells.  
 
The unique mouse ES cell properties are routinely maintained by extra-cellular signals 
and intra-cellular regulators. Through binding to cell-membrane receptors, extra-cellular 
factors can induce nucleus-directed signaling pathways to control genes expression.  Two 
main important signal factors maintain the normal growth of ES cell in the absence of 
serum. One is leukaemia inhibitor factor (LIF), and the other is bone morphogenetic 
protein (BMP).   
 
1.2.1 LIF-Stat3 signaling pathway  
Experience from culturing mouse EC cells indicates that feeder cells or conditional 




be cocultured with mouse MEF feeders in the presence of serum. The conditioned 
medium can support the normal growth of ES cells in the absence of feeders indicating 
that fibroblasts are producing signals inhibiting ES cell differentiation. The active 
component, LIF is subsequently identified from the conditioned medium59, 60.  
 
It further has been demonstrated that LIF binds to its receptor (LIFR) which has a 
cytoplasmic tail to activate the signaling pathway. As next step in the signaling cascade, 
the LIF-LIFR complex recruits signal transducer glycoprotein 130 (gp130) to form a 
trimetric complex which binds and activates tyrosine kinase Jak. Subsequently, Stat3 is 
recruited to the receptor complex and phosphorylated by Jak. The activated Stat3 will 
homodimerize and then translocate into nucleus to regulate its downstream target genes61. 
 
The intact LIF-Stat3 signaling pathway is required for ES cell growth under normal 
culturing conditions. LIF-deficient fibroblasts are reported to be incapable of supporting 
ES cell self-renewal62. Recruitment and activation of Stat3 is essential for self-renewal of 
ES cells and expression of an inhibitory Stat3 mutant in ES cells forces differentiation61, 
63, 64. ES cells heterozygous for the Stat3 can only be isolated from E14 cells, a cell line 
least dependent on LIF for self-renewal65.  
 
Although the LIF-Stat3 signaling pathways are critical for maintenance of ES cells, in 
vivo knockout studies indicate that most components of the pathways are not important at 
the preimplantation stage when mouse ES cells are derived. Female mice lacking 




indicating that expression of LIF in mice is essential for implantation62. Disruption of 
Stat3 causes early, postimplantation embryonic lethality between E6.5 and 7.566. 
Targeted mutation of LIFR causes perinatal death and embryos homozygous for the 
gp130 mutation progressively die between 12.5 dpc and term67-69. Jak1-/- mice are runted 
at birth, fail to nurse, and die perinatally. Jak2-/- embryos are anemic and die around 12.5 
dpc. Jak3 deficient mice have profound reductions in thymocytes and severe B cell and T 
cell lymphopenia similar to severe combined immunodeficiency disease (SCID)70-74. 
These results demonstrate that signaling requirements for embryo development in vivo 
and ES cell growth in vitro are different.  
 
1.2.2 BMP-Smad signaling pathway 
In serum-free medium, LIF alone is insufficient to prevent mouse ES cell differentiation. 
Another growth factor BMP4 alone can drive ES cells into non-neural differentiation. 
However, mouse ES cells can be sustained in combination with LIF and BMP in the 
absence of serum37.  
 
BMPs belong to the transforming growth factor beta (TGF-β) family which controls a 
plethora of cellular responses in animal development. In general, a TGF-β ligand acts 
through heterodimers of type I and type II receptor serine/threonine kinases on the cell 
surface. Receptor II will phosphorylate the receptor I kinase domain, which then 
propagates the signal through phosphorylation of the Smad proteins75.  
 
Alk3 is the only type I BMP receptor detectable in the pluripotent ICM and early 




obtained from blastocysts, highlighting the importance of BMP signaling through Alk3 in 
maintaining pluripotency77.  
 
Ying et al. showed that BMPs induce the expression of Id (inhibitor of differentiation) 
through the Smad pathway. Id, an inhibitor of basic helix-loop-helix transcription factors, 
can replace BMPs in promoting mouse ES cell proliferation in the presence of LIF 
alone37.  Qi et al. suggested that BMPs might also act through inhibition of the mitogen-
activated protein kinase (MAPK) pathways independent of Smads77. These findings 
suggest that the self-renewal of mouse ES cells is achieved by a delicate balance between 
the two cytokines, LIF and BMP.  
 
 
1.2.3 Wnt signaling pathway  
For cells without Wnt signal, β-catenin is degraded through interactions with a complex 
containing Axin, Adenomatous Polyposis Coli (APC), and glycogen synthase kinase-3β 
(Gsk-3). The canonical Wnt pathway is initiated upon Wnt protein binding to the 
Frizzled/LRP receptor complex on the cell surface. Dishevelled, a key componet of the 
Wnt receptor complex inhibits a complex including Axin, Gsk-3 and APC. Inactivation 
of Gsk-3 results in stabilization and accumulation of β-catenin in the cytoplasm and 
nucleus. β-catenin in collaboration of T cell specific factors (Tcfs) regulates Wnt 
downstream targets. Wnt signaling can also be activated by direct, intracellular inhibition 





Wnt signaling components have been shown to regulate self-renewal of ES cells. 
Activation of Wnt signaling, by genetically eliminating the function of the negative 
regulator APC, promotes the undifferentiated phenotype of mouse ES cells79. Activation 
of the Wnt pathway by 6-bromoindirubin-3'-oxime (BIO), a specific pharmacological 
inhibitor of Gsk-3, maintains the undifferentiated phenotype in mouse or human ES cells 
and sustains expression of ES-specific transcription factors Oct-4, Rex-1 and Nanog80. 
Mouse ES  cells deleted of GSK-3α/β display hyperactivated Wnt/β-catenin signaling and 
are severely compromised in their ability to differentiate81. Tcf3, a Wnt controlled 
transcription factor, represses Nanog and Oct4 which are required for mouse ES cell self-
renewal and pluripotency82, 83.  
 
1.2.4 Ras signaling pathway 
Ras-MAPK 
Growth factors such as EGF, FGF will initiate the signaling pathway through binding to 
receptor tyrosin kinases (RTKs) resulting in receptor dimerization, autophosphorylation 
and activation. This will cause the activation of a number of intracellular signaling 
cascades, including the Ras-MAPK pathway. Ras proteins belong to a superfamily of low 
molecular weight GTP-binding proteins whose regulation depends on their binding to 
GTP or GDP.  Activated Ras leads to activation of a MAP kinase signaling cascade, 






Much evidence has indicated that the Ras-Mek-Erk pathway plays important roles in 
mouse ES proliferation and differentiation. Ectopic expression of Ras is able to drive ES 
cell differentiation. Conditional activation of a mutant form of Ras in ES cells in vitro 
enables derivation of trophoblast stem (TS) cell lines which contribute to chimerize 
placental tissues in vivo84.  Mek inhibitor is shown to facilitate the derivation of the ES 
cell lines from mouse embryos, especially those of recalcitrant mouse strains85. Fgf4 null 
embryos developmentally arrest shortly after implantation86. Deletion of Fgf4, a main 
stimulus of Ras-Mek-Erk pathway in ES cells, leads to compromised differentiation 
capacity into different cell lineages. Erk2-null ES cells fail to undergo either neural or 
mesodermal differentiation in adherent culture and retain expression of pluripotency 
markers87. These results suggest Fgf4 and Ras-Erk signaling cascade play a critical role 
in the decision between self-renewal and differentiation.  
 
Recently, Ying et al. showed that the derivation, propagation and pluripotency of ES cells 
is independent of extrinsic stimuli. Suppressing activities of mitogen-activated protein 
kinase (MAPK) and glycogen synthase kinase 3 (GSK) through small molecular 
inhibitors will enable ES cell self-renewal without LIF and BMP4 signaling88. Stat3 null 
ES cells and recalcitrant-derived ES lines, which can not be isolated and maintained in 
traditional methods, are obtained from the defined medium bypassing the cytokine 
signaling88. More importantly, rat ES cells, another rodent pluripotent cells, have been 
successfully derived from rat preimplantation embryos using the same conditions. The rat 
ES cells have been shown to be able to contribute comprehensively to primary chimeras 




state that is intrinsically self-maintaining if shielded effectively from inductive 
differentiation stimuli”88.  
 
Eras-PI3K pathway 
Takahashi et al. reported that mouse ES cells specifically express ES cell-expressed Ras 
(Eras) which interacts with phospphatidylinositol-3-OH kinase (PI3K) but does not with 
Raf. Eras null ES cells are pluripotent but show significantly retarded growth and less 
tumorigenicity89.  
 
Phosphoinositide 3-kinases (PI3-kinases or PI3Ks) are a family of related enzymes that 
are capable of phosphorylating the 3 position hydroxyl group of the inositol ring 
of phosphatidylinositol (PtdIns). PI3Ks consist of p110 catalytic subunit and adaptor 
subunit complexes and are regulated by growth factors through receptor tyrosine kinases. 
Activated PI3Ks phosphorylate PtdIns(3,4)P2 and generate PtdIns(3,4,5)P3 as a second 
messenger. A serine/threonine kinase, Akt, binds to PIP3 through its pleckstrin homology 
(PH) domain and is translocated to the inner cell membrane, where it is phosphorylated 
and activated by another serine/threonine kinase PDK1. Activated Akt regulates the 
function of numerous substrates, such as Mdm2, IKK, and mammalian target of 
rapamycin (mTOR), and plays import roles in  various cellular responses90. As a strong 
candidate for the downstream targets of the ERas/PI3K signaling in ES cells, mTOR is 
shown to be essential for both ES cell proliferation and mouse development91.   
 




The external signaling pathways such as LIF and BMP4 finally lead to activation of the 
transcription factors Stat3 and Smad1 which will translocate into the nucleus and result in 
the transcriptional regulation of their downstream targets. Apart from the signaling 
pathways related transcription factors such as Stat3 and Smad1, another set of 
transcription factors that are important for ES cell growth have been discovered, such as 
Oct4, Sox2 and Nanog.   
 
1.3.1 Oct4 
Oct4 (also known as Oct3) encoded by Pou5f1 belongs to POU (Pit-1, Oct-1 and Oct-2, 
unc-86) transcription factor family which shares a conserved POU domain. The POU 
domain is a bipartite DNA-binding structure92. The POU domain of Oct4 has two 
subdomains, one is the N-terminal specific region (POUs), and the other is C-terminal 
homeodomain (POUh). Both subdomains are tethered by a helix-turn-helix structure.  
Both POU-specific and POU-homeo domains are reported to be essential for binding 
activity to octamer sequence ATGCAAAT. Regions flanking the POU domain are shown 
to be not critical for DNA binding and show little sequence conservation. Both N-
terminal and C-terminal regions of Oct4 have transactivation functions, and C-terminal 
domain is cell type specific and its specificity is mediated by the Oct4 POU domain93-95.  
 
Oct4 is initially screened out by analyzing various adult organs and different 
developmental stages of mouse embryos for the presence of octamer-binding proteins. 
Oct4 is found in unfertilized oocytes, epiblast, primordial germ cells in vivo and 





Oct4 is maternally expressed in unfertilized eggs. The initial expression begins during 
cleavage stage. At the first cell fate decision stage, Oct4 is downreguated in the 
trophectoderm and strictly maintained in the ICM. Expression of Oct4 remains in the 
epibast of pre- and post-implantation embryos, then strictly in the migratory primordial 
germ cells98.  
 
Oct4 knockout studies indicate that “the activity of Oct4 is essential for the identity of the 
pluripotential founder cell population”. Oct4-deficient embryos develop to form 
developmentally compromised blastocysts whose ICM cells fail to acquire the potential 
to differentiate into multiple lineages. These embryos restrict to differentiation and only 
give rise to the extraembryonic trophoblast cells in vitro99.  Conditional gene targeting of 
Oct4 is performed for primordial germ cells and results show that loss of Oct4 function 
leads to apoptosis of primordial germ cells100. Oct4 gene ablation is carried out for many 
other somatic tissues which results in no abnormalities in homeostasis or regenerative 
capacity101. These results indicate the critical functions of Oct4 in its exclusively 
expressed cells.  
 
Expression of Oct4 is associated with an undifferentiated phenotype of ES cells. A 2-fold 
induction of Oct4 causes ES cell differentiation into primitive endoderm and mesoderm. 
On the other hand, repression of Oct4 induces ES cell differentiation to trophectoderm102. 
The fine-tuning regulation of Oct4 is required for maintaining the level of its expression 





The first differentiation event result in the separation of the early embryo blastocyst into 
into two different types: trophectoderm and inner cell mass. Oct4 functions to suppress 
differentiation of embryonic cells into trophectodem where Oct4 is silenced. It is reported 
that a transcription factor Cdx2 is responsible for the suppression of Oct4 and normal 
development of trophectodem lineage103, 104.   
 
To understand the specific expression pattern of Oct4, the regulation regions of Oct4 has 
been revealed by many studies. Two distinct enhancer elements are found in the upstream 
of the Oct4 promoter by an Oct4 transgenic reporter study. One is the distal enhancer (DE) 
which drives Oct4 in the morula, ICM and primordial germ cells. The other is the 
proximal enhancer (PE) which activates Oct4 in epiblast105. The detailed comparison 
between different species of Oct4 promoter shows that there are 4 highly conserved 
regions (CR) 1-4106 (Figure 1.1). Many transcription factors are found to target the 
conserved regions.  Several members of the nuclear receptor family, including LRH-1, 
Sf-1, Gcnf, regulate Oct4 expression by binding to its enhancer and promoter regions107-
109. Oct4 expression is regulated by Oct4/Sox2 complex by targeting to the CR4 region in 
ES cells110, 111. Sall4 is shown to bind to the highly conserved regulatory region of the 
Oct4 distal enhancer and activate Oct4 expression in vivo and in vitro112. Global mapping 
studies show that Nanog, Smad1 and Stat3 might regulate Oct4 by binding to conserved 
regions40, 113. Apart from transcription factors, epigenetic regulators are shown to regulate 
the Oct4 expression. Epigenetic silencing of Oct4 at the promoter region is initiated by a 




DNA methylation by the enzymes Dnmt3a/3b114. Although many transcription factors 
and epigenetic modifier are found in regulation of Oct4, the detailed mechanisms on how 
they are precisely controlled in vivo and reactivated in reprogramming still need to be 
addressed.  
 
As a transcription factor, Oct4 also regulates downstream genes that are important for 
self-renewal and pluripotency. Cdx2, a critical transcription factor required for the 
development of a functional trophectoderm and TS cell self-renewal, is repressed by Oct4 
in pluripotential founder cell in vivo and ES cells in vitro103, 104. Fgf4, a growth factor 
controlled by Oct4, is essential for normal trophobast development, TS cell self-renewal, 
and lineage specification commitment87, 99.  These results provide some detailed roles of 
Oct4 in the first cell specification event. Oct4 also targets to Nanog, Sox2, Fbx015, Rex1 
















Figure 1.1 A schematic diagram illustrating the regulatory elements and 
transcriptional regulators of Oct4 
(a) Oct4 promoter contains important regulatory regions. Distal enhancer (DE) and 
proximal enhancer (PD) are two enhancer regions. Four highly conserved regions (CR1-4) 
are shown as colored boxes: yellow, blue, green and red.   
(b) Regulatory regions of Oct4 receive multiple inputs. Oct4, Sox2, Smad1, Stat3, Nanog, 
Sall4, Cdx2 bind to CR4 region. CR2 region is targeted by Nanog and LRH-1. LRH-1, 






1.3.2 Sox2  
Sox2 (SRY (sex determining region Y)-box 2) belongs to the Sox transcription factor 
family which harbors a HMG specific DNA binding domain. Mouse Sox2 is expressed in 
the pluripotent cells, in the extraembryonic ectoderm, and in germ cells. After 
gastrulation, Sox2 is expressed in the neural tube from the earliest stages of its 
development (neural plate)117, 118. Sox2 is expressed highly in the neuroepithelium of the 
developing central nervous system (CNS) and in adult neural stem cells119. These results 
indicate possible functions of Sox2 in pluripotent lineage, in neural development and in 
homeostasis of the adult CNS.  
 
Avilion et al. reported that Sox2 null blastcysts contain a relative normal ICM, but fail to 
maintain an epiblast and are unable to give rise to the Sox2 null ES cell lines120. The 
expression pattern of Oct4 and Sox2 are overlapped in pri- and post-implantation epiblast, 
germ cells and ES cells. Both of them are essential for derivation of ES cell lines from the 
blastocysts. These results suggest that Sox2 and Oct4 function together to maintain the 
pluripotency.  
 
Sox2 is shown to bind to heptamer CATTGTA and form a ternary complex with Oct-4 
protein on Fgf-4 enhancer121, 122. Numerous Sox2-Oct4 target genes are found to have 
Oct4 octamer and sox2 heptamer separated by either 0 or 3 bp. Crystal structure analysis 
and modeling reveal that Oc4 and Sox2 are able to dimerize onto different enhancers in 




Sox-Oct elements of Oct4, Sox and Nanog as a binary complex and regulate their 
expression in mouse and human ES cells110, 115.   
 
The functions and regulatory mechanisms of Sox2 in ES cells are revealed by using 
inducible Sox2-null mouse ES cells. Suppression of Sox2 in ES cells leads to 
differentiation into trophectoderm-like cells, as Oct4 null cells or suppression of Oct4 99, 
103, 124.  However, the expression of Sox-Oct4 enhancer dependent genes including Oct4, 
Sox2, and Nanog is not reduced dramatically at an early time course, suggesting that 
Sox2 is dispensable for the activation of these Sox-Oct enhancers. Oct4 is shown to 
restore the loss of pluripotency in Sox2-null ES cells, indicating that the essential 




Nanog is a homeodomain-containing transcription factor. Two independent groups 
discovered the important roles of Nanog for ES cell-renewal125, 126. One isolated Nanog 
through a functional screening for molecules that are capable of directing ES cell self-
renewal in the absence of LIF125. The other group applied digital differential display to 
compare EST libraries from mouse ES cells and those from various somatic tissues126. 
Both demonstrate that ectopic expression of Nanog relieves ES cell self-renewal from 





Nanog protein contains 3 domains, N-terminal domain (ND), homodomain (HD) and C-
terminal domain (CD) (Figure 1.2a). The homodomain is responsible for the specific 
DNA recognition. ND and CD are shown to have transactivation activities127. Nanog CD 
is separated by a WR domain into CD1 and CD2 domain. The WR domain in Nanog is 
10 pentapeptide repeats starting with a tryptophan (W) residue. The WR domain is 
identified to be in charge of the Nanog dimerization. Nanog dimerization is required for 
Nanog tansactivation and interaction with other pluripotency network proteins128, 129.  
 
Nanog is initially expressed after the 32-cell stage of early embryos, and is later restricted 
in pre- and post-implantation epiblast, and in primordial germ cells126, 130. Mitsui et al. 
showed that Nanog ablation in vivo causes a failure in the specification of early embryo 
pluripotent cells, which adopt a differentiated visceral/parietal endodermal fate. Nanog is 
highly expressed in undifferentiated ES cells. Disruption of Nanog in ES cell specifies 
cell fate exclusively into extraembryonic endoderm lineages126. However, Chambers et al. 
observed that Nanog protein and its expression fluctuates in mouse ES cells. Although 
Nanog null ES cells are prone to differentiation and expand slowly, they are able to self-
renew, contribute to different germ layers and be recruited to the germ line.  Primordial 
germ cells fail to mature on reaching the genital ridge without Nanog131.  These results 
argue against Nanog serving an essential role in conjunction with Oct4 and Sox2 in the 
transcriptional machinery of pluripotency40, while indicate that Nanog is required for cell 






Independent studies show that depletion of Nanog by RNAi impairs ES self-renewal and 
induces cell differentiation, while overexpression of Nanog strengthens ES self-renewal 
independent of LIF signaling pathway40, 125, 126, 132. These results highlight the critical role 
of Nanog for ES cell maintenance. Expression of Nanog is tightly regulated in ES cells 
(Figure 1.2b). Oct4 and Sox2 bind to the Nanog proximal promoter and positively 
regulate its expression115. As an interacting partner of Oct4, Zfp143 regulate Nanog 
expression through modulation of Oct4 binding133. Foxd3, a member of the forkhead 
family of transcriptional regulators, positively regulates Nanog expression by modulating 
the Nanog promoter134. Nanog also binds strongly to its own distal enhancer region. Sall4, 
a member of spalt-like protein family, is shown to interact with Nanog and co-occupy 
many Nanog targets including Pou5f1, Sox2, Nanog and Sall4135. Nanog expression is 
up-regulated in mouse ES cells by the binding of T (Brachyury) and Stat3 to an enhancer 
element136.  Smad1 is also shown to be a partner of Nanog and is enriched at the Nanog 
distal enhancer113, 136. Loss of Tcf3 in ES cells impairs the ability of these cells to 
differentiation by relieving the repression of Nanog82, 83, 137.  Lin et al. reported that the 
tumor suppressor,  p53,  binds to the promoter of Nanog and suppresses its expression 
after DNA damage138.  
 
Post-transcriptional and Post-translational regulation can influence the stability and 
translation efficiency of mRNAs as well as the activity and interactions of proteins. 
MicroRNA miR-134, upregulated during ES cell differentiation, is found to specifically 
target the coding region of Nanog mRNA and attenuate its translation139, 140. Nanog 




Nanog phosphorylation need to be determined. A recent study uncovered a novel mode of 
regulating Nanog at the posttranslational level. Caspase-3, a major component of the 
programmed cell death pathway, is shown to be involved in inducing Nanog cleavage in 
differentiating ES cells142. These different regulating mechanisms may allow ES cells to 


















Figure 1.2 A schematic diagram illustrating monomer and dimer of Nanog and 
regulatory elements and transcriptional regulators of Nanog 
(a) Nanog domains. Nanog protein contains 3 domains, N-terminal domain (ND), 
homodomain (HD) and C-terminal domain (CD). CD is separated by a WR domain into 
CD1 and CD2 domain. Different domains are indicated by colored boxes. Nanog 
dimerization depends on WR domain.  
(b) Regulatory regions of Nanog receive multiple inputs. Two key regulatory regions 
(enhancer and proximal promoter) are shown as red and orange bars. T, Nanog, Sall4, 
Stat3 and Smad1 bind to Nanog enhancer. Oct4, Sox2, Foxd3 and Zfp143 occupy the 




1.3.4 Klf transcription factor  
Krüppel-like factors (Klfs) are named after the Drosophila embryonic pattern regulator 
Krüppel. There are 17 Krüppel-like factor members identified in mammals so far. These 
Klf members contain conserved DNA binding domains and occupy the similar DNA 
binding motifs143. The Klf transcription factors play diverse roles in proliferation, 
differentiation, development and cell death.  Many Klf members have been shown to 
have critical roles in mouse development by gene targeting approach (Table 1.1). Klf1 
null embryos die of anaemia during fetal liver erythropoiesis and show the molecular and 
haematological features of beta-globin deficiency, found in beta-thalassaemia144.  Klf2 -/- 
embryos die between E12.5 and E14.5 from severe intra-embryonic and intra-amniotic 
hemorrhaging coupled with specific defects in blood vessel morphology. In addition, 
single-positive T cell quiescence and survival also require the intact functions of Klf2145. 
Klf3 knockout mice have less white adipose tissue, and their fat pads contain smaller and 
fewer cells146. Klf4-/- mice die shortly after birth due to loss of skin barrier function and 
demonstrate a 90% decrease in the number of goblet cells in the colon147, 148. Klf5 -/- 
embryos die before E8.5 and Klf5 +/- mice show diminished levels of arterial-wall 
thickening, angiogenesis, cardiac hypertrophy and interstitial fibrosis in response to 
injury149. Klf6 -/- embryos die by E12.5 and are associated with markedly reduced 
hematopoiesis and poorly organized yolk sac vascularization150. Loss of Klf7 activity in 
mice leads to neonatal lethality and a complex phenotype which is associated with 
deficits in neurite outgrowth and axonal misprojection at selected anatomical locations of 
the nervous system151. Klf9 null mice have a normal life span but females show reduced 




Klf10 -/- mice have increased osteoblast numbers with no increase in bone formation 
parameters and Klf10 -/- null mouse derived osteoblasts are defective in mineralization 
and in support of osteoclast differentiation in vitro154. Klf13 -/- mice have reduced 
numbers of circulating erythrocytes and a larger spleen155. The Klf15 null mice are viable, 
fertile and have a normal lifespan but are prone to induce cardiac hypertrophy156.  Klf11 
null mice do not show evident pathological defects157. There is no knockout data 
available for the rest of Klf transcription factors (Klf8, Klf12, Klf14, Klf16, and Klf17).  
 
Klf4 is shown to upregulate p21 and suppress p53 gene directly in mouse fibroblast 
cells158, 159.  MEF cells null for the Klf4 gene are genetically unstable160. These results 
support a crucial role for Klf4 in regulating cell proliferation and maintaining genetic 
stability.  
 
Recent reports on the reprogramming of somatic cells to pluripotent cells highlight a 
critical role of Klf4 in remodeling cell fate56. Klf4 is found to be induced by LIF 
signaling pathway in mouse ES cells, and gain of function assay shows that Klf4 can 
inhibit EB induced differentiation161.  Paradoxically, Klf4 alone is not important for the 
self-renewal state of mouse ES cells although it can directly regulate Lefty1 gene 
expression in mouse ES cells162.  Analysis of published expression profiles of LIF 
withdrawal or retinoic acid (RA) treatment induced differentiation shows that Klf2, Klf4 
and Klf5 are found to be highly expressed in undifferentiated ES cells and downregulated 
during cell differentiation 132, 163. However, the functions of Klf4 and other family 





Table 1.1 The phenotypes of the Klf knockout mice 
 
 
1.3.5 Other factors 
Allele Symbol Gene; Name Synonyms Primary knockout phenotype 
Klf1; Krüppel-like factor 1  EKLF Lethal beta-thalassemia at E14.5 
Klf2; Krüppel-like factor 2  LKLF Lethal cardiac failure at E12.5 to E14.5 
Klf3; Krüppel-like factor 3  BKLF, Tef-2 Viable with less white adipose tissue 
Klf4; Krüppel-like factor 4  EZF, Gklf, Zie Peri-natal failure of skin barrier 
Klf5; Krüppel-like factor 5 Bteb2, CKLF, IKLF Early embryonic death before E6.5 





Lethal failure of erythropoiesis and yolk sac 
vascularisation at E12.5 
Klf7; Krüppel -like factor 7  UKLF Severe neurological defects 
Klf8; Krüppel-like factor 8 BKLF3, ZNF74 - 
Klf9; Krüppel-like factor 9 BTEB-1, Bteb1, Klf9 
Viable with impaired uterine development and 
defective embryo implantation 




Viable with bone defects, impaired skeletal 
development 
Klf11; Krüppel-like factor 11 Tieg2, Tieg2b, Tieg3 
Viable with no phenotype 
observed 
Klf12; Krüppel-like factor 12 AP-2rep - 




Viable with defects in T cell differentiation 
Klf14; Krüppel-like factor 14 BTEB5 - 
Klf15; Krüppel-like factor 15 CKLF, KKLF Viable with increased susceptibility to cardiac hypertrophy 
Klf16; Krüppel-like factor 16 BTEB4, DRRF - 
Klf17; Krüppel-like factor 17 Zfp393 - 




Besides the transcription factors mentioned above, more factors have been found to be 
involved in ES cell self-renewal and pluripotency. A RNAi knockdown screening 
approach demonstrates that depletion of Oct4, Sox2, Nanog, Tbx3, Esrrb, Tcl1, Dppa4 
and Mm.34388 can induce ES cell differentiation132. Suppression of Nr0b1 
(Dax1) expression, either by knockdown or inducible knockout method, induces ES cell 
differentiation164. Zic3 is reported to play an important role in the maintenance of 
pluripotency by preventing endodermal lineage specification in ES cells165. c-Myc has 
been implicated in promoting the self-renewal of ES cells under the LIF-Stat3 pathway166. 
Knockout of Ronin compromises the growth of ES cells while forced expression of Ronin 
allows ES cells to proliferate without differentiation in the absence of LIF167.  
 
1.3.6 Epigenetic regulators  
Recently, epigenetic regulators have been reported to play important roles in ES cell 
maintenance and differentiation.  DNA methlylation is involved in adding a methyl group 
to DNA without altering the DNA sequences by DNA methytransferases. DNA 
methlylation plays important roles in imprinting, X-chromosome inactivation, and 
suppression of repetitive elements. In mammals, DNA methyltransferase 1(Dnmt1) is 
important in the maintenance of the the DNA methylation pattern during DNA replication. 
Dnmt3a and Dnmt3b are the de novo methyltransferases that can build up DNA 
methylation patterns required in normal developmental processes168, 169. Although Dnmt1 
mutant ES cells are viable and show no obvious abnormalities with respect to growth rate 
or morphology, Dnmt1 deficiency leads to enhanced microsatellite instability in ES 




and die when induced to differentiation172. Later-passage hypomethylated Dnmt (3a-/-, 
3b-/-) ES cells are unable to form teratomas in vivo173, 174 and differentiate upon LIF 
withdrawal due to low levels of DNA methylation175.  
 
In ES cells, the promoters of a subset of genes are repressed but become induced during 
differentiation. These regions have been shown to be marked with “bivalent” histone 
modifications that correlate with both activation (H3K4me3) and inactivation 
(H3K27me3)176. These markers are the results of the activities of Trithorax-group (trxG) 
and Polycomb-group (PcG) proteins. PcG proteins comprise at least two kinds of 
complex PRC1and PRC2 which work together to carry out their repressive effect. PcG 
proteins are critical for normal embryo development as deletion in mice of PRC2 genes, 
including Ezh2, Eed, Suz12, are shown to be embryonic lethal177-179. ES cells can not be 
derived from blastocysts without the PRC2 component Ezh2177.  Eed and Suz12 null ES 
cells strongly tend to differentiate or are impaired in proper differentiation180, 181. 
Interestingly, H2AZ, a histone H2A variant, is identified to be enriched at polycomb 
complex target genes in ES cells and is necessary for lineage commitment182. These 
results highlight the critical functions of DNA methlylation, histone modifications and 
histone variants in ES cell differentiation processes.  
 
1.3.7 Transcriptional regulatory network 
The transcriptional regulatory network comprises a specific group of transcription factors 
and their co-regulators that collaborate to produce specific expression program for certain 




analysis such as ChIP-on-chip and ChIP-PET, is carried out for transcription factor Oct4, 
Sox2 and Nanog in mouse and human ES cells. The results show that Oct4, Sox2 and 
Nanog share a substantial portion of their target genes and auto-regulate each other as 
well as synergistically regulate downstream target genes, hence forming a tight regulatory 
network40, 183. 
   
Apart from the core regulators, more transcription factors have been found to concertedly 
build up the ES cell regulatory network by genomic-wide location analysis.  Kim et al. 
applied in vivo biotinylation mediated ChIP (bioChIP) to genome-wide locating 
(bioChIP-chip) of a set of factors associated with pluripotency of mES cell including  
somatic cell reprogramming factors (Oct4, Sox2, Klf4, and c-Myc) and others (Nanog, 
Dax1, Rex1, Zpf281, and Nac1). Their target genes are found to be grouped into two 
classes: promoters bound by few factors are often inactive or silenced, whereas promoters 
bound by multiple factors tend to be active in the undifferentiated state184. Independently, 
Chen et al. mapped the binding sites of 13 transcription factors (Nanog, Oct4, STAT3, 
Smad1, Sox2, Zfx, c-Myc, n-Myc, Klf4, Esrrb, Tcfcp2l1, E2f1, and CTCF) and 2 
transcription co-regulators (p300 and Suz12) in ES cells by using chromatin 
immunoprecipitation (ChIP) coupled with ultra-high-throughput DNA sequencing (ChIP-
seq). The selective factors are known to play different roles in ES cell biology as 
components of the LIF and BMP signaling pathways, self-renewal and pluripotency 
regulators, and key reprogramming factors.  Analysis reveals there are highly dense 
binding loci or multiple transcription factor binding loci (MTL) in the ES cells. The 




Sox2-Nang cluster, the other is the Myc cluster. Transcriptional co-activator p300 is 
specifically recruited to the Oct4-Sox2-Nanog cluster but not to the Myc cluster, 
depending on Oct4, Sox2 and Nanog. Fragments from a subset of the Oct4-Sox2-Nanog 
cluster are shown to have ES specific enhancer activities. This data demonstrates that 
these MTL genomic loci as well as multiple transcriptional regulators might function 
together as specific enhanceosomes in ES cells. Interestingly, Stat3 and Smad1, the key 
components of the LIF and BMP signaling pathways respectively, co-occupy many 
binding targets with the core transcription factors Oct4, Sox2 and Nanog, indicating that 
the two key signaling pathways are integrated to the Oct4, Sox2, and Nanog 
transcriptional network through Smad1 and Stat3113. This data provides a framework for 
understanding the transcriptional regulatory networks and suggest a more comprehensive 
and complex view of the pluripotency network in ES cells than prior work. 
 
Besides mapping of the transcriptional regulatory network by genomic-wide location 
analysis, analysis among the different networks will provide us more clues for 
understanding the unique networks in stem cells. For example, there is only a small 
portion of Oct4 or Nanog target genes overlap between mouse and human ES cells40. One 
possible explanation for the limited overlap between the mouse and human is that there 
might be different between species. Independent groups applied genome-scale location 
analysis to identify Oct4 targets in mouse ES cells, EpiSCs and human ES cells. The data 
confirm the result showing limited overlap of Oct4 targets between mouse ES cells and 
human ES cells, while showing a 7-fold greater overlap of Oct4 targets between human 




and Nanog, they fail to colonize the embryo. Ectopic expression of Klf4 can reprogram 
EpiSCs into iPS cells. These EpiSC derived induced pluripotent stem (Epi-iPS) cells 
produce high-contribution chimeras and show germline transmission185. Considering the 
similar condition used in culturing human and EpiSCs and regulatory network between 
them, human ES cells are more akin to EpiSCs than mouse ES cells.   
 
Recent progresses indicate that transcriptional regulatory network in ES cells is much 
more complicated than the current models. First, Nanog deficient ES cells can still 
incorporate into all different lineages including early stage of primordial germ cells. 
Second, the differentiation phenotype of Sox2 knockout ES cells can be rescued by Oct4 
expression. Third, ES cells have an innate program for self-renewal that does not require 
extrinsic signal instruction when the differentiation pathways are suppressed. Fourth, 
more regulators have been found to play an important role in ES maintenance, such as 
Zic3, Esrrb, Zfp143.   
 
1.3.8 Methods to study the network  
Genetic screen by RNAi 
RNAi is a valuable research tool which can specifically and robustly down-regulate gene 
expression. RNAi-mediated pathways are induced by transfection of synthesized small 
interfering RNAs (siRNAs) or introduction of vectors expressing short hairpin RNAs 
(shRNAs) into cells. shRNA will be processed by Dicer and  then loaded into RNA-
induced silencing complex (RISC) to induce sequence specific mRNA degradation or 




systematically shut down each gene in the cell.  For example, Oct4, Sox2, Nanog, Tbx3, 
Esrrb, Tcl1, Dppa4, Mm.34388 and Tip60-p400 are identified to be important for ES cell 
self-renewal and pluripotency by RNAi screening approach132, 187.  
 
ChIP 
Chromatin immunoprecipitation (ChIP) is an approach to determine the chromatin 
context of a genomic region or the location of DNA binding sites on the genome for a 
particular protein in vivo. The development of tools for genome-wide location analysis of 
in vivo protein-DNA interactions, such as ChIP-on-chip,  ChIP-PET or ChIP-seq, now 
allow global views of transcription factor binding and chromatin context. Genome-wide 
location analysis is able to identify regulatory regions, reveal the chromatin context at 
regulatory regions, and establish a framework for understanding the transcriptional 
regulatory networks.  
 
DNA Microarray  
Microarray technology allows us to examine many genes at once and determine the 
dynamics of the gene expression for many samples. For example, microarray-based gene 
expression profiling can be used to identify genes whose expression is changed in 
response to specific gene knockdown or overexpression.  
 
Proteomics  
Proteomics is the large-scale study of protein structures and functions. Proteomics can be 




interactions in protein complexes. For instance, a protein interaction network in ES cells 
is mapped by using combination tagging and proteomics. Target proteins such as Nanog, 
Oct4 and Rex1 are fused with an N-terminal Flag epitope and a short peptide tag that 
serves as a substrate for in vivo biotinylation. Interaction partners have been successfully 
identified by a combination of single step purification and tandem purification, followed 
by mass spectrometry188. Recently, a new proteomics of isolated chromatin segments 
(PICh) can address the full set of proteins that regulate specific loci.  A specific nucleic 
acid probe can be used to isolate genomic DNA with its associated proteins in sufficient 
quantity and purity to allow identification of the bound proteins189.  
 
1.4 Reprogramming of somatic cells 
During animal development, cell differentiation is thought to be an irreversible process 
and specified cell types are non-switchable between each other. However, researchers 
found that cell fate is actually reversible and exchangeable in some cases.  
 
A good example of converting the cell fate is to switch a range of non-muscle cell types 
into muscle cells by ectopic expression of a transcription factor MyoD which is a master 
regulator for myogenesis190, 191. Switching cell fate has also been successfully achieved in 
the hematopoietic system by overexpressing key transcription factors, such as Gata-1, 
Gata-3 and C/EBP192.   
 
The dominant effect of transcription factors in redirect cell differentiation is best 




transcription factors: Oct4, Sox2, Klf4 and c-Myc56. Recently, exocrine cells of pancreas 
can be converted to the endocrine beta cells in vivo by introducing three transcription 
factors Pdx1, Ngn3 and MafA which is required for beta pancreas differentiation193. 
 
These results indicate that key transcription factors have unique functions to remodel the 
specific transcriptional regulatory network and rebuild the epigenetic landmark. Most 
importantly, these exogenous transcription factors are no longer required to maintain the 
network. Apart from transcription factors, epigenetic modifiers also play important roles 
in the remodeling processes. Inhibition of DNA methylation and histone modification are 
able to dramatically increase the reprogramming efficiency or substitute for some 
transcription factors194, 195.  
 
1.5 Purpose and scope 
As a potent reprogramming factor, the roles of Klf4 in ES cells are obscure.  The purpose 
of this thesis is to elucidate the functions of Klf4 and Klf family members in maintaining 
the unique property of ES cells by functional genomics. More specifically, the objectives 
of this thesis are to:  
• investigate the biological functions of Klfs in ES cells by RNAi knockdown.  
• identify the binding loci of Klfs in ES cells by ChIP-on-chip.  
• understand the molecular basis of the redundancy by EMSA and luciferase  
enhancer reporter assay. 
•  measure changes of the gene expression controlled by Klfs 





This project aims to decipher the functions of Klfs in mouse ES cells by using advanced 
functional genomics approaches. Combinatorial information provided in this study will 
contribute to a better understanding of ES cell biology and reprogramming. 
• The functional results obtained should be valuable to the stem cell field as roles of 
this family are not well studies.   
• The results of genomic-wide location analysis will refine the transcriptional 
regulatory network in the ES cells.  
• Study of the binding motifs and their related activities in the binding element will 
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CHAPTER II MATERIALS AND METHODS 
2.1 Cell culture and transfection 
Feeder-free E14 mouse ES cells were cultured at 37°C with 5% CO2. All cells were 
maintained on gelatin-coated dishes in Dulbecco’s modified Eagle medium (DMEM; 
GIBCO), supplemented with 15% heat-inactivated fetal bovine serum (FBS; GIBCO), 
0.055 mM β-mercaptoethanol (GIBCO), 2 mM L-glutamine, 0.1 mM MEM nonessential 
amino acid, 5,000 units/ml penicillin/streptomycin and 1,000 units/ml of LIF (Chemicon) 
as described previously. Transfection of shRNA and over-expression plasmids was 
performed using Lipofectamine 2000 (Invitrogen) according to manufacturer’s 
instructions. Briefly, 1.5 µg of plasmids were transfected into ES cells on 60mm plates 
for RNA and protein extraction. Detection of alkaline phosphatase, which is indicative of 
the nondifferentiated state of ES cells, was carried out using a commercial ES Cell 
Characterization Kit from Chemicon. For RNAi-ChIP assay, 12 µg of plasmids were 
transfected into ES cells on 150mm plates. Puromycin (Sigma) selection was introduced 
1 day after transfection at 0.8 µg/ml, and maintained for 2 to 6 days prior to harvesting.  
 
2.2 RNA extraction, reverse transcription and quantitative real-time PCR 
Total RNA was extracted using TRIzol Reagent (Invitrogen) and purified with the 
RNAeasy Mini Kit (Qiagen). Reverse transcription was performed using SuperScript II 
Kit (Invitrogen). DNA contamination was removed by DNase (Ambion) treatment, and 
the RNA was further purified by an RNAeasy column (Qiagen). Quantitative PCR 
analyses were performed in real time using an ABI PRISM 7900 Sequence Detection 
System and SYBR Green Master Mix as described. For all the primers used, each gave a 
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single product of the right size. In all our controls lacking reverse transcriptase, no signal 
was detected. 
 
2.3 ChIP assay 
ChIP assays with feeder-free mouse ES cells were carried out as previously described. 
Briefly, cells were cross-linked with 1% formaldehyde for 10 min at room temperature 
and formaldehyde was then inactivated by the addition of 125 mM glycine. Chromatin 
extracts containing DNA fragments with an average size of 500 bp were 
immunoprecipitated using antibodies. For all ChIP experiments, quantitative PCR 
analyses were performed in real-time using the ABI PRISM 7900 sequence detection 
system and SYBR green master mix as previously described. Relative occupancy values 
were calculated by determining the apparent immunoprecipitation efficiency (ratios of the 
amount of immunoprecipitated DNA to that of the input sample) and normalized to the 
level observed. 
 
2.4 ChIP-on-chip assay 
We carried out three biological replicate ChIP experiments to obtain ChIP enriched DNA. 
Amplification of the linker-ligated ChIP DNA using ligation mediated-PCR and labeling 
of DNA samples for ChIP-chip were followed by NimbleGen protocol. Briefly, each of 
test and reference DNA samples (1 μg) was denatured in the presence of 5′ Cy3-or Cy5-
labeled random nonamers (TriLink Biotechnologies) and incubated with 100U (exo-) 
Klenow fragment (New England Biolabs) and dNTP mixture [6 mM each in TE buffer 
(10 mM Tris, 1 mM EDTA, pH 7.4; Invitrogen)] for 2 h at 37°C. Reactions were 
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terminated by addition of 0.5 M EDTA, pH 8.0, precipitated with isopropanol, and 
resuspended in water. Then, 13 μg Cy5-labeled ChIP sample and 13 μg Cy3-labeled total 
sample were mixed, dried down, and resuspended in 40 μL hybridization buffer 
(NimbleGen Systems). After denaturation, hybridization was carried out in a MAUI® 
(MicroArray User Interface) Hybridization System ( BioMicro Systems, Salt Lake City, 
UT, USA) for 18 h at 42°C. The arrays were washed using wash buffer system 
(NimbleGen Systems), dried by centrifugation, and scanned at 5 μm resolution using the 
GenePix® 4000B scanner (Axon Instruments). Fluorescence intensity raw data were 
obtained from scanned images of arrays using NimbleScan™ 2.0 extraction software 
(NimbleGen Systems). For each spot on the array, log2-ratios of the Cy5-labeled test 
sample versus the Cy3-labeled reference sample were calculated. Then, the biweight 
mean of this log2 ratio was subtracted from each point; this procedure is approximately 
equivalent to mean-normalization of each channel. Please refer to Supplementary 
Methods for data analysis. 
 
2.5 Generation of antibodies 
cDNA encoding the N-terminus of mouse Klf2 (amino-acids 90-255), Klf4 (amino-acids 
1-320) or Klf5 (amino-acids 1-320) was cloned into pET42b (Novagen) for the 
production of GST-fusion protein with 6 His tagged at the C-terminus. The recombinant 
proteins were produced in BL21 after IPTG induction and purified with GSH-sepharose 
(Pharmacia) and Ni-NTA-sepharose (Qiagen) column. The purified antigens were then 
used to immunize rabbits for polyclonal antibodies production. 
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2.6 Plasmids construction 
shRNA constructs were designed as previously described. Two shRNA constructs each 
for Klf2, Klf4 and Klf5 were designed to target 19 base-pair gene-specific regions. 
Oligonucleotides were cloned into pSuper-puro (BglII and HindIII sites; Oligoengine).  
pSuperpuro constructs were used to express shRNA against luciferase (Firefly) or GFP 
as controls. ClaI-XhoI sites were used to insert different H1-shRNA cassette from other 
shRNA constructs digested by BstBI-XhoI to make double or triple RNAi constructs. The 
H1 promoter cassette in pLVTH lentivirus vector was replaced by the H1-shRNA 
cassette excised from pSUPER-puro, generating LV-shRNA plasmid. The coding regions 
of Klf2, Klf4 and Klf5 were amplified by RT-PCR, and cloned into pCAG-3HA-hyg. For 
reporter assays in ES cells, DNA constructs used in reporter assays were cloned into the 
pGL3 plasmid (Promega) (BamH I and Sal I sites) downstream of a luciferase gene 
driven by Pou5f1 (Oct4) minimal promoter. 
 
2.7 Custom design genomic tilting arrays 
Custom genomic tilting arrays were manufactured by NimbleGen. This microarray 
design contained probes interrogating 402 genes and 4 gene clusters at a 45 bp tiling 
interval. Sequences derived from 20 miRNA genes; 7 imprinted loci; 7 germ cell marker 
genes; 1 oocyte gene; 155 genes expressed in ES cells; 129 genes expressed in 
differentiated cells; 79 control genes and 8 cell cycle genes were present on this 
microarray. The single array contains more than 360,000 50mer probes selected from 57 
megabases of mouse sequence (May 2004, mm5 build) and we surveyed 50 kb 
surrounding each gene. See appendix for a list of genes and their coordinates. 
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2.8 ChIP-on-chip data analysis 
Identification of binding regions 
For each probe, a ratio between its signal from transcription factor specific antibody and 
that from the control antibody was taken and subsequently log2-transformed. Tamalpais 
program196 was applied to identify the peak regions on each of the triplicate ChIP-on-chip 
samples with a p-value cutoff of 0.05. Tamalpais computes the p-value for a peak by 
calibrating, to a geometric distribution, the number of consecutive probes whose log 
ratios are among top 5% largest log ratios of all the probes on the array. A binding region 
of a transcription factor is further determined by requiring two out of the three ChIP-on-
chip replicates to have peaks at the same chromosomal location. 
 
Significance analysis of overlaps of binding regions 
260, 896 and 720 binding regions were computed for Klf2, Klf4 and Klf5, respectively. 
The Venn diagram shows that there are all together 1167 non-redundant binding regions 
and 205 overlaps of binding regions that bind all of the three transcription factors. A 
Monte Carlo simulation was performed to assess the significance of the overlapping 
binding regions. The simulation randomly drew 260, 896 and 720 objects from a total of 
1,167 objects for 100,000 times. A p-value less than 0.00001 was derived from the 
proportion of the random draws whose overlaps were larger than the size of the actual 
overlap, 205. 
 
2.9 DNA microarray 
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mRNAs derived from triple knockdown shRNA and Luc shRNA treated ES cells were 
reverse transcribed, labeled and analyzed using Illumina microarray platform (Sentrix 
Mouse-6 Expresion BeadChip v1.1). Arrays were processed as per manufacturer’s 
instructions. Three biological repeats of profiles (each for control and triple knockdown) 
were used to generate statistically significant gene lists. The microarray data were 
analyzed by SAM. The thresholds for the differentially expressed genes were (I) more 
than 1.5 fold change and (II) q-value of less than 0.05. 
 
2.10 Electrophoretic mobility shift assays (EMSAs) 
Recombinant proteins of the Klf DNA binding domain (GST tagged) were used for the 
gel shift assays. The DNA binding domains were cloned into the pET42b (Novagen) 
vector. The proteins were expressed and purified with GSH-sepharose beads (Amersham). 
Eluents were dialyzed against a dialysis buffer (10 mM Tris-HCl, pH 7.4, 100 mM NaCl, 
10 mM ZnCl2 and 10% glycerol) at 4°C for 6 h. Proteins were stored at -80°C. 
Concentrations of proteins were verified with the Biorad protein measurement assay. For 
EMSA, DNA oligonucleotides (Proligo) labeled with biotin at the 5’ end of the sense 
strands were annealed with the antisense strands in the annealing buffer (10 mM Tris-
HCl, pH 8.0, 50 mM NaCl, 1 mM EDTA) and purified with agarose gel DNA extraction 
kit (Qiagen). DNA concentrations were determined by the NanoDrop ND-1000 
spectrophotometer. The gel shift assays were performed using a LightShift 
Chemiluminescent EMSA kit (Pierce Biotechnologies). 100 ng of protein were added to a 
5 µl reaction mixture (final) containing 1 µg of poly(dI-dC) (Amersham), 1 ng of 
biotinlabeled oligonucleotide in the binding buffer (12 mM HEPES, pH 7.9, 12% 
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glycerol, 60 mM KCl, 0.25 mM EDTA, 1 mM DTT). Binding reaction mixtures were 
incubated for 20 min at room temperature. Binding reaction mixtures were resolved on 
pre-run 6% native polyacrylamide gels in 0.5X Tris-buffered EDTA. Gels were 
transferred to Biodyne B nylon membranes (Pierce Biotechnologies) using Western blot 
techniques and detected using chemiluminescence. 
 
2.11 Luciferase reporter assay 
For reporter activity, 300 ng of reporter constructs and 0.5 ng Renilla luciferase 
(pRLCMV; Promega) were co-transfected into the ES cells. Firefly and Renilla luciferase 
activities were measured 48 h after transfection with the Dual Luciferase System 
(Promega) using a Centro LB960 96-well luminometer (Berthold Technologies). For 
RNAi luciferase assays, 200 ng of shRNA plasmids was co-transfected with the reporter 
and Renilla luciferase constructs. Puromycin selection was introduced 12 h after 
transfection at 1.0 µg/ml. Firefly and Renilla luciferase activity were measured 48-60 h 
after transfection.  
 
2.12 Apoptosis assay  
Annexin V staining was used to investigate the levels of apoptosis. ES cells were 
transfected with LV-shRNA (GFP) constructs for 72 h before they were harvested and 
labeled Annexin V-PE Apoptosis Detection Kit (BD Pharmingen; catalog number 
559763) for cytometric assay. As positive control, ES cells were treated with 2 µg/ml 
camptothecin (Sigma-Aldrich) for 12 h to trigger apoptosis. Cells were trypsinized and               
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single cell suspensions were stained with Annexin V-PE according to the manufacture’s 
instructions. 
 
2.13 Embryo collection, RNA isolation, reverse transcription, and real-time PCR 
analysis 
Embryos were collected from B6CBAF1 females (age 6–8 weeks) that had been 
superovulated with 5 IU PMSG (Calbiochem) followed by injection of 5 IU hCG (Sigma) 
48 hrs later and after successful mating with ICR males. MII oocytes were collected 48 h 
post-PMSG injection. Embryos dissected at the appropriate time post-fertilization were 
collected and pooled in M2 medium prior to RNA extraction. Pools of 150 oocytes or 
embryos were collected at each stage. Total RNA was extracted from pooled embryos 
using the PicoPure RNA isolation kit (Arcturus Bioscience). cDNA synthesis was at 
37°C for 2 h using the high capacity cDNA archive kit (Applied Biosystems). The 
subsequent PCR reaction mixes were loaded onto low density array (LDA) plates and run 
on a 7900HT Sequence Detection System (Applied Biosystems). 4.7 embryo equivalents 
were loaded into each port with a port leading to 48 reaction wells. TaqMan real-time 
primer probe sets (Klf2-Mm00500486_g1; Klf4-Mm00516104_m1; Klf5-
Mm00456521_m1; Oct4-Mm00658129_gH; Cdx2-Mm00432449_m1; Tbp- 
Mm00446973_m1) were aliquoted into the reaction wells of the LDA by the 
manufacturer (Applied Biosystems). Two technical replicates for each gene at each 
developmental time point were generated. Threshold cycle (Ct) values were calculated 
from the system’s software (SDS 2.2) and used as a direct measure of gene expression. 
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The equation (36-Ct) POWER1.9 was used to determine the fold-change above 
background with the background level of detection set at a Ct of 36. 
 
2.14 Retrovirus packaging and infection.  
Coding sequences of Klfs were amplified from mouse ES cells by RT‑PCR and cloned 
into MMLV-based pMXs retroviral vector. The retroviruses were generated as described 
previously. To induce iPS cells, equal amounts of viruses encoding different factors were 
applied to mouse embryonic fibroblasts (MEFs) at 50–70% confluence in DMEM 
containing 15% FBS and 6 ng/L polybrene. After 24 h, the medium was replaced with 
fresh MEF medium and on the following day (2 dpi), the cells were split as 1:6 to 1:20 on 
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Table  2.1 Quantitative realtime RCR primers 
Gene  Sense  Antisense 
Klf2 ATGGCGCTCAGCGAGCCTATCTT CAATCCCATGGAGAGGATGAAGTC 
Klf4 GAACTCACACAGGCGAGAAACCTTA CTCTTCATGTGTAAGGCAAGGTGGT 
Klf5 GCCTCAGTGGTAGACCAGTTCTTCA CTCTGGTGGCTGAAAATGGTAACAG 
Pou5f CATACTGTGGACCTCAGGTTGGACT AGTTGGTTCCACCTTCTCCAACTTC 
Nano GGTTTGCCTAGTTCTGAGGAAGCAT TCAGGACTTGAGAGCTTTTGTTTGG 
Esrrb GCCTCAAAGTGGGGATGCTGAAGGAAGGTG GCCAATTCACAGAGAGTGGTCAGGGCCTTG 
Tbx3 TCCACAAACTGAAACTCACCAACAA CAGTAACGGCGATGAATTCTGTTTC 
Nr5a2 GCCATGTCTCAGGTGATCCAAGCAATGCCC GGGTACTCAGACTTGATGGCCCGACTAGGA 
Zfp42 CAGAGAAGCCAGAGGGCGGTGTGTA  GCTTCTCTCCGGTGTGCACCAGAAA  
Jmjd1 TGCCTTCCAGGTTTGATGATCTGATGG CCCACATAAACCATGACATTGGCTGCA 
Nes CAGAGAGGGGACCTGGAACATGAAT CCTGGCCACTGATATCAAAGGTGTCT 
Fgf5 GAGAGTGGTACGTGGCCCTGAACAAGAGAG CTTCAGTCTGTACTTCACTGGGCTGGGACT 
En1 GTGGTCAAGACTGACTCACAGCAAC GTGATATAGCGGTTTGCCTGGAACT 
Gata4 AAGCTCCATGGGGTTCCCAGGCCTCTTGCAAT TGAATGTCTGGGACATGGAGCTGCTGTGCC 
Gata6 TGTGCAATGCATGCGGTCTCTACAGCA  TTCATAGCAAGTGGTCGAGGCACCC  
 
 
Table 2.2 RNAi sequences 
Gene Target sequence 1 Target sequence 2 
Klf2 GGCAAGACCTACACCAAGA GTGAGAAGCCTTATCATTG 
Klf4 GAGGAACTCTCTCACATGA GACCACCTTGCCTTACACA 
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Table 2.3 Antibodies used for ChIP  
Factor  Source  Catalog Number Anitgen 
Klf2 custom made  amino-acids 90-255 
Klf4 custom made  amino-acids 1-320 
Klf5 custom made  amino-acids 1-320 
Nanog Cosmo Bio REC-RCAB0002PE  
p53 Santa Cruz Sc-100  
HA Santa Cruz Sc-7392  











































CHAPTER III RESULTS  
Reprogramming is a process of inducing highly differentiated cells to reverse their 
developmental potential to attain the pluripotent state. Ectopic expression of four 
transcription factors (Oct4, Sox2, c-Myc and Klf4) are sufficient to convert fibroblasts to 
induced pluripotent stem (iPS) cells that have many characteristics of ES cells56. These 
iPS cells are genetically and epigenetically similar to ES cells and express ES-cell-
specific markers. In a proof-of-principle experiment, iPS cells combined with gene and 
cell therapy were used to correct the defective human sickle haemoglobin allele in 
mice197. Hence, the derivation of specialized cell types from autologous iPS cells could 
be developed for potential therapeutic applications in different disease models.  
 
Transcription factors Oct4, Sox2, c-Myc and Klf4 are also referred to as reprogramming 
factors. Oct4 and Sox2 have been shown to be critical for the self-renewal state of ES 
cells and c-Myc has also been implicated in promoting the self-renewal of ES cells40, 102, 
124, 132, 166. Klf4 belongs to the Krüppel-like factor (Klf) family of evolutionarily 
conserved zinc finger transcription factors that regulate numerous biological processes, 
including proliferation, differentiation, development and apoptosis198. The functions of 
Klf4 and other family members in ES cells are largely unknown.  
 
3.1 Klf2, 4 and 5 are required for the maintenance of mouse ES cells  
3.1.1 Individual Klf is not essential for the mouse ES growth  
Mouse ES cells are able to grow in culture dishes by using a combination of feeders, 




and colony-like morphology and express specific alkaline phosphatase (AP). Upon 
differentiation, ES cells will lose typical morphology and stain poorly for alkaline 
phosphatase. To examine the functional roles of Klf4 in ES cells, RNAi was used to 
deplete the endogenous expression of the factor. Two independent short-hairpin RNA 
(shRNA) constructs targeting different regions of the Klf4 transcript were used to make 
sure that the knockdown effects were specific. The knockdown effect by RNAi can be 
tested by RT-PCR. The Klf4 transcript after knockdown was reduced to 20 percent or less 
compared to that in control ES cells (Figure 3.1a). Alkaline phosphatase staining 
indicated by red color and observations of morphological change were used to evaluate 
whether the ES cells underwent differentiation. Consistent with a previous report162, no 
change in morphology and alkaline phosphatase staining in the ES cells was observed, 
indicating that Klf4 alone is not required for the maintenance of undifferentiated state of 
ES cells (Figure 3.1b).  
 
Considering Klf4 is one of the Krüppel-like factor (Klf) family members, we 
hypothesized that other Klf transcription factors enriched in undifferentiated ES cells 
may play a redundant role with Klf4. To this end, published time-course expression 
profiling of retinoic acid (RA)-treated ES cells were analyzed to identify other Klfs that 
are upregulated in undifferentiated ES cell state132. In addition to Klf4, two other Klfs 
(Klf2 and Klf5) were enriched in ES cells and downregulated upon RA induced 
differentiation (Figure 3.1c). To address the roles of Klf2 (also known as lung Krüppel-
like factor) and Klf5 (also known as intestine-enriched Krüppel-like factor), their 




change in morphology and alkaline phosphatase staining were observed (Figure 3.1e), 

















Figure 3.1 Individual Klf2, Klf4 and Klf5 is not essential for the mouse ES growth 
(a) Quantitative real-time PCR analysis of Klf4 expression after knockdown using two 
shRNA constructs (K4-1 and K4-2) targeting different regions. The levels of the 
transcripts were normalized against control Luc shRNA transfection. Error bars represent 
the s.e.m. of three technical replicates. 
(b) Depletion of Klf4 by RNAi. Typical colony morphology of ES cells with positive 
alkaline phosphatase staining (red) was maintained after Klf4 knockdown using two 
shRNA constructs targeting different regions of Klf4. Flattened fibroblast-like cells were 
formed after Nanog depletion. In control Luc shRNA transfected cells, normal 
undifferentiated phenotype with distinct ES cell colonies was maintained.  
(c) Klf2, Klf4 and Klf5 are down-regulated upon ES cell differentiation. Expression of 16 
members of the Klf family at different days after RA induced differentiation. The 
microarray expression data is obtained from the literature.  
(d) Quantitative real-time PCR analysis of Klf2 and Klf5 expression after knockdown 
using two shRNA constructs (K2-1 and K2-2 for Klf2, and K5-1 and K5-2 for Klf5) 
targeting different regions of the respective genes. The levels of the transcripts were 
normalized against control Luc shRNA transfection. Error bars represent the s.e.m. of 
three technical replicates.  
(e) Depletion of Klf2 and Klf5 by RNAi. Normal undifferentiated ES colonies with 
positive alkaline phosphatase staining were maintained after knockdown using two 




3.1.2 Klf2, Klf4 and Klf5 are required for the maintenance of ES cells 
Next, it would be interested to examine whether Klf2 or Klf5 can replace functions of 
Klf4 in ES cells.  Systematic pair-wise double knockdown constructs which targeting two 
different transcripts were made by cloning two different RNAi cassettes into one shRNA 
vector. Each double knockdown construct are capable to knockdown two different Klf 
transcripts at the same time. As there are two independent shRNA for each Klf factor, six 
double knockdown constructs were cloned to ensure that the knockdown effects were 
specific (Figure 3.2a).  The results revealed no change in morphology and alkaline 





To further investigate whether any of Klf2, Klf4 or Klf5 alone is sufficient for the ES 
growth, triple knockdown using two independent constructs with each construct targeting 
the three Klf transcripts at different regions was then performed. RT-PCR result showed 
that RNAi effects were not compromised when three different factors simultaneously 
depleted (Figure 3.2c). Remarkably, the colony morphology of the ES cells was lost and 
they resembled fibroblasts. The alkaline phosphatase staining was also lost, indicative of 
differentiation (Figure 3.2d). Thus, depletion of Klf2, Klf4 and Klf5 led to differentiation 








Figure 3.2 Klf2, Klf4 and Klf5 are required for the maintenance of ES cells 
(a) Depletion of two Klfs by combinatorial double RNAi. Quantitative real-time PCR 
analysis of Klf2, Kfl4 and Klf5 expression after knockdown using shRNA constructs 
targeting two Klfs of Klf2, Klf4 and Klf5. The levels of the transcripts were normalized 
against control Luc shRNA transfection. Error bars represent the s.e.m. of three technical 
replicates. 
(b) Concurrent knockdown of two Klfs using constructs targeting the respective Klfs. 
Undifferentiated ES colonies with positive alkaline phosphatase staining were maintained 
after knockdown using shRNA constructs targeting two of Klf2, Klf4 and Klf5.  
(c) Depletion of the three Klfs by triple RNAi. Quantitative real-time PCR analysis of 
Klf2, Kfl4 and Klf5 expression after knockdown using two sets of shRNA constructs 
targeting Klf2, Klf4 and Klf5. The levels of the transcripts were normalized against 
control Luc shRNA transfection. Error bars represent the s.e.m. of three technical 
replicates. 
(d) Triple knockdown of Klf2, Klf4 and Klf5 with two constructs targeting different 
segments of the Klf transcripts. Differentiated cells with negative alkaline phosphatase 
staining were formed after knockdown using two sets of shRNA constructs targeting Klf2, 
Klf4 and Klf5. 
 
3.1.3 Specificity of Klf RNAi  
RNAi is widely used for functional genomic studies and screens in a number of 
organisms199-202. However, recent studies have shown that siRNA-mediated silencing 
may be less specific than was originally believed203, 204. Several assays were performed to 
confirm the specificity of our RNAi experiments. 
 
To rule out the possibility that differentiation phenotype by Klf triple RNAi is derived 
from over-saturating RNAi pathways, control triple RNAi constructs were made by 
replacing one Klf RNAi cassette with Klf10 RNAi in Klf triple RNAi construct. As one 
of Krüppel-like factor family members, Klf10 is expressed in ES cell according to the 
RT-PCR. The results revealed no change in morphology and alkaline phosphatase 




knockdown effects of control triple RNAi constructs were confirmed by RT-PCR 
(Figure 3.3b). 
For the RNAi experiments, off-target effects can not be excluded even by using 
independent RNAi constructs. “The key control for an RNAi experiment, which should 
be provided whenever technically feasible, is rescue of the observed RNAi phenotype by 
artificial expression of a RNAi-resistant form of the targeted mRNA”205. Rescue 
experiment remains the gold standard control for specificity in RNAi experiment, 
especially for multiple RNAi. To further confirm the results of the knockdown 
experiments, RNAi-resistant constructs encoding Klf2, Klf4 or Klf5 was made by silent 
mutating the RNAi target sequences. The results showed that RNAi-resistant Klf2, Klf4 
or Klf5 cDNA was able to rescue the differentiation phenotype induced by Klf triple 
knockdown (Figure 3.3c). However, Klf10 was unable to rescue this phenotype. The 
concurrent requirement for Klf2, Klf4 and Klf5 in the maintenance of self-renewal of ES 
cells strongly suggests that they are functionally redundant.  
 
Virus-based RNAi vector systems have some advantages over transient vector systems or 
RNAi duplex in terms of stable expression of shRNA and high transduction efficiency206.  
To further confirm the results of Klf triple RNAi effect in ES cells, triple RNAi cassette 
was conferred to a lentivirus-based RNAi vector containing a constitutive marker GFP. 
The high virus transduction efficiency was shown as most ES cells express GFP after 
virus infection. The ES cells were flatten and fibroblast-like upon two independent virus 





The triple knockdown cells showed reduced proliferation rates compared to control RNAi 
cells by counting of cell number (Figure 3.3e). To test whether triple knockdown cells 
undergo apoptosis, early marker annexin-V was measured after Klf triple RNAi.  The 
results showed that triple knockdown cells did not undergo apoptosis as the number of 













Figure 3.3 Specificity of Klf knockdown by RNAi  
(a) Differentiated cells with reduced alkaline phosphatase staining were formed after 
depletion of Klf2, Klf4 and Klf5. Undifferentiated ES colonies with positive alkaline 
phosphatase staining were maintained after knockdown using shRNA constructs targeting 
Klf10 in conjunction with any other two Klfs. The scale bar represents 100 μm.  
(b) Quantitative real-time PCR analysis of gene expression after triple Klf knockdown. 
The levels of the transcripts were normalized against control Luc shRNA transfection. 
Error bars represent the s.e.m. of three technical replicates. 
(c)  Rescue of triple knockdown phenotype with coexpression of RNAiresistant cDNAs 
of Klf2, Klf4 or Klf5. Typical colony morphology of ES cells with positive alkaline 
phosphatase staining (red) was restored in triple knockdown cells with coexpression of 
RNAi-resistant cDNA constructs of Klf2, Klf4 or Klf5. Klf10 was unable to rescue the 
differentiation induced by depletion of Klf2, Klf4 and Klf5. The scale bars represent 100 




(d) Triple knockdown of Klf2, Klf4 and Klf5 with two sets of LV-shRNA constructs 
targeting different segments of the Klf transcripts. Flattened fibroblast-like cells were 
formed after transduction of lentivirus produced by Klfs triple RNAi constructs. For 
control lentivirus transducted cells, normal undifferentiated phenotype with distinct ES 
cell colonies was maintained. GFP signal was detected by fluorescent microscope. The 
scale bar represents 100 μm. 
(e) Proliferation rate of ES cells transfected with control, Klf triple RNAi set 1 or Klf 
triple RNAi set 2 constructs was determined by counting cells recovered at different days. 
Numbers of cells counted is average of 3 different wells from 2 independent experiments. 
The ES cells were seeded at 1.5 ×105 cells in six-well dishes and cells from each well 
were harvested and counted on 4 consecutive days. 
(f) Apoptosis assay. Quantification of Annexin V positive cells after knockdown using 
two sets of LV-shRNA constructs targeting Klf2, Klf4 and Klf5. Percentage of Annexin 
V positive cells were detected by FACS sorting of GFP positive cells.  
 
 
3.2 Mapping of Klf2, Klf4, Klf5 and Nanog binding loci by ChIP-on-Chip  
The concurrent requirement for Klf2, Klf4 and Klf5 in the maintenance of self-renewal of 
ES cells strongly suggests that they are functionally redundant. To identify the in vivo 
targets of these Klfs, chromatin immunoprecipitation (ChIP) was used to determine the 
binding loci and profiles of these proteins.  
 
3.2.1 Characterization of antibodies raised against Klf2, Klf4 and Klf5 
Currently, the chromatin immunoprecipitation technique is the most precise method to 
identify specific proteins or chromatin modifications associated with a region of the 
genome or, conversely, identification of regions of the genome associated with specific 
proteins and chromatin modifications in vivo.  Specific ChIP-grade antibody is critical for 
the success of Chromatin IP. ChIP-grade antibodies must be highly specific and 
recognize the epitope in the chromatin context and under fixed conditions. As Klf2, Klf4 





Polyclonal antibodies were generated against the divergent amino-termini (Figure 3.4a).  
Western blot was used to characterize the antibodies and results showed that each Klf 
antibody can recognize a distinct band with correct size in the ES cell extracts. More 
importantly, the signal of the bands could be depleted by Klf RNAi (Figure 3.4b). To 
further test whether there are cross-react activities among the three Klf antibodies, 
immunoprecipitation were performed. HA tagged Klf2, Klf4 or Klf5 was overexpressed 
in 293T cells respectively, and cell extracts were subjected to carry out 
immunoprecipitation. The results showed that each Klf protein was specifically 
recognized and pulled down by its own antibody but not other Klf anitbodeis or control 
GST antibody (Figure 3.4c). Taken together, our raised Klf antibodies can specifically 




















Figure 3.4 Characterization of antibodies raised against Klf2, Klf4 and Klf5 
(a) Schematic representation of the Klf molecule (adapted from Richard P, 2007). Shown 
are the three C-terminal C2H2 zinc fingers, each chelating a single zinc ion. The fingers 
are linked by the “TGERP”-like motif, which assists in binding to target DNA. The 
activation/repression domain is found at the N-terminus of the molecule. 
(b) Protein changes at different days after knockdown of Klf2, Klf4 and Klf5. Western 
blot analyses of ES cell extracts were carried out using anti-Klf2, anti-Klf4 and anti-Klf5 
antibodies. The ES cells were either transfected with control or triple knockdown RNAi 
constructs and extracts were harvested at different days. 
(c) Characterization of antibodies raised against Klf2, Klf4 and Klf5 by 
immunoprecipitation. 3HA-Klf2, 3HA-Klf4 and 3HA-Klf5 were overexpressed in 293T 
cells. The 293T cell lysates were harvested 48 h after transfection. Cell lysates were 
subjected to immunoprecipitation using anti-GST, anti-Klf2, anti-Klf4 or anti-Klf5. The 
immunoprecipitates were analyzed by Western blotting with anti-HA monoclonal 
antibody. 
 
3.2.2 ChIP-on-chip assay for Klf2, Klf4, Klf5  
ChIP-on-chip assay is a useful tool for genome-wide mapping of in vivo protein–DNA 
interactions, and allowing global views of transcription factor binding and chromatin 
context. ChIP-on-chip can help to identify regulatory regions, unravel the chromatin 
features at specific types of regulatory regions, and establish how transcription factors 
and chromatin modifications are coordinated to control gene expression in the genome.  
 
To obtain the global views of Klf transcription factor binding in living cells, ChIP-on-
chip were performed by using ES cells extracts. The ChIP-enriched DNA or input 
genomic DNA was amplified and the Cy5- and Cy3-labelled DNA was hybridized onto 
custom-designed genomic tiling microarrays. This microarray design contained probes 
interrogating 402 genes and four gene clusters at a 45 bp tiling interval. Probe Sequences 
were derived from 155 genes expressed in ES cells, 129 genes expressed in differentiated 
cells and 122 “control” genes. More than 360,000 50mer probes were selected from 57 





Interestingly, the ChIP-on-chip analysis revealed that Klf2, Klf4 and Klf5 bound to genes 
encoding key regulators such as Pou5f1 (encoding for Oct4), Sox2, Nanog, Esrrb, Tcl1, 
Sall4, Tcf3 and Mycn40, 99, 120, 132, 162, 166, 207 (Figure 3.5). The binding profiles at genes 
compared between Klf2, Klf4 and Klf5 are remarkably similar. Control ChIP against p53, 














Figure 3.5 Identification of in vivo binding sites of Klf4, Klf2 and Klf5 by ChIP-on-
chip. 
Binding profiles of Klf4, Klf2 and Klf5 at Esrrb, Fbxo15, Nanog, Tcl1, Sox2, Pou5f1, 
Sall4, Mycn and Tcf3 loci. The ChIP-on-chip result for each transcription factor is 
represented by a different colour (Klf4, red; Klf2, blue; Klf5, green; control p53, black). 
y axis shows the log2 ratio (LogR). Screen shots of the SignalMap browser showing Klf4, 
Klf2 and Klf5 binding at Esrrb, Fbxo15, Nanog, Tcl1, Sox2, Pou5f1, Sall4, Mycn and 
Tcf3 genomic loci are shown. 
 
 
3.2.3 Validation of Klf2, Klf4, Klf5 ChIP-on-chip 
To validate the signals from ChIP-on-chip experiments, different assays were carried out 
to verify the binding of Klf to the regions of genome.  
 
Conventional ChIP–qPCR was performed and the binding of Klf proteins at Esrrb, 
Fbxo15, Nanog and Tcl1 loci were validated by real-time PCR analysis (Figure 3.6a).  
The binding profiles at Nanog and Fbxo15 promoter regions were also validated by 
scanning their promoter regions (Figure 3.6b) (Table 3.1). The data showed that the 
binding patterns of three Klfs were prominently similar to the profiles obtained from the 
ChIP-on-chip.   
 
To rule out the possibilities of non-specific binding by raised antibodies, ChIP using the 
epitope HA antibody was performed to profile the binding patterns of epitope tagged Klfs 
expressed in ES cells. The profiles of ectopically expressed HA–Klf2, HA–Klf4 and HA–
Klf5 at the Nanog promoter, and three other loci, were identical to those obtained from 
ChIP against endogenous proteins. Control ChIP using anti-HA antibody with ES cell 





To demonstrate further that the ChIP enrichment was specific, each Klf was depleted by 
RNAi and the occupancy of all three Klf proteins was analysed by ChIP. The binding of 
each Klf was reduced by shRNA constructs targeting the corresponding Klf transcript, 
indicating that the ChIP signal for each Klf was specific (Figure 3.6d). Most importantly, 
the data showed that the other Klf proteins were bound to the target sites when one of 
them was depleted by RNAi. Therefore, the depletion of one Klf can be compensated for 





















Table 3.1 ChIP primers for Nanog and Fbxo15 
Nanog 
Label  Sense Antisense 
1 AACATTTAAAGTGTGAAAGAATGACTCCC AAATTTCATTGATAGACTCCTGGTTACCAT 
2 CCTGGCTGGTGATTCTCCTTCAAGGGCTAA CATCATCAGTATCAGGGGCAGCTATTGTGT 
3 TGGTGATTCTCCTTCAAGGGCTAAGATTAC TCTTTTGCCAGCATCATCAGTATCAGGG 
4 GCCTCAGGAAGAATGAAGCTC AAAAACTCAGAAAAGCATAACATGAA 
5 CCCGGAGGACTCCAAGGCTAGCG CGGTTTGAATAGGGAGGAGGGCGTCT 
6 GCCACCTCTTCGCTCGGATCTTTCAC TTGCCTCTGGGTCCACGGAGTCA 
7 AGCTCTTACAATTCCTCTCCCGGACGGTT AGCCCAGCAAACTACCTTCACTAGGCCAAA 
8 CTTGAGTGTGGCAAAAGTATGTAACTGGGA GGGGCCCATCGCTAACATATTGAAG 
9 GGGCCCCGTGCTTTAGATTTTAGGCTT ACAAGTGTGTTTTACCCGCTGAGCATTCTG 
10 TCCGAGTACTTAACTCAACATACCATTCTTCGT CCTGATGTGATTCTTGTCATTAGGCAAAG 
11 GCATAAACCTTGATATTTTGAACGGCCTATT ACAGATGGACTAAAGCCCCTAAGTAGAAATCAT 
12 AAAATCCATGCAGGCAAAACACCAAT CATAAACTAATGTGGCTGGTTGACCTCTGTC 
13 CCCAAACCAAAAAGAGCCATTCAAGCTTAGTCT GCCGATCAGTCCTTGTGCTCACAGATAAGT 
14 GGCCTCTACATTAATTTAAACACTCCTTAA CAAGTCTGAAGAAAGAGCCTGTGTC 
15 CCAGGTTTCCCAATGTGAAGAGCAAGC GGCGATCTCTAGTGGGAAGTTTCAGGTCAA 
16 TAGATCAGAGGATGCCCCCTAAGCTTTCCC CTCCTACCCTACCCACCCCCTATTCTCCC 
17 GTGGGAAGGCTGCGGCTCACTT AGTGTGATGGCGAGGGAAGGGATTTCT 
18 CTTACAAGGGTCTGCTACTGAGATGCTCTGCAC GGACACCCGCTTATGTTAATGACTACTACGGTTCA 




Label  Sense Antisense 
1 ATCTTTATTGGTGGTCCTTGGATTAAC GCTGCTTTGCTATTTTCACACACTATTC 
2 AGCAGACAGGCTTGACTGTTTTTCTATACC CACACAGCAACAACAGAGAGCCTAGCAAT 
3 GGTCTAGGAGGAGGCAGAGTTGGTTGTTA CTTATGCAGGATTGGTCATACCTATGATTT 
4 TTCTGTTATGATTGAAAGGTTTGGGTTCTA GCCGTGCAATAAGTCAAACTGTATCCTC 
5 CCCCTGTAAATTCACTCAGAGGATACAGT TGGTCCACCTTAACAGTTTATCTAACAAGC 
6 GCCCTTAGTTCCCAGATGTGCTTTATCATA AAAGTAGGGTGAGGCAGTTTGCTTAGCAG 
7 CGATGGGCTGTGATCATTTCTAGAGTAGGC CTCACTCAGCTTCCACCCCTTGTTGCTC 



















Figure 3.6 Validation of Klf2, Klf4, Klf5 ChIP-on-chip 
(a) Klf2, Klf4 and Klf5 occupy Esrrb, Fbxo15, Nanog, Tcl1 loci in ES cells. ChIP assay 
was performed using using anti-Klf2 (blue), anti-Klf4 (red), anti-Klf5 (green) antibodies 
with extract derived from ES cells. Control ChIP was performed with anti-GST antibody. 
Error bars represent the s.e.m. of three technical replicates. 
(b) Validation of Klf2, Klf4 and Klf5 binding. Klf2, Klf4, Klf5 and Nanog bind to Nanog 
promoter region. ChIP assay was performed using anti-Klf2 (blue), anti-Klf4 (red), anti-
Klf5 (green) and anti-Nanog (purple) antibodies with extracts derived from ES cells. 
Schematic showing the location of the amplicons (black bars labeled 1-19) used to detect 
ChIP-enriched fragment over the 8.2 kb Nanog promoter. Amplicons are numbered in 
order relative to their sites along the gene. The grey box represents an exon. Fold 
enrichment is the relative abundance of DNA fragments detected by real-time PCR at 
amplified region over a control amplified region. GST antibody was used as a ChIP 
control (grey). Error bars represent the s.e.m. of three technical replicates.  
Klf2, Klf4, Klf5 and Nanog bind to Fbxo15 promoter region. ChIP assay was performed 
using anti-Klf2 (blue), anti-Klf4 (red), anti-Klf5 (green) and anti-Nanog (purple) 
antibody with extract derived from ES cells. Schematic showing the location of the 
amplicons (black bars labeled 1-8) used to detect ChIP-enriched fragment over the 2.3 kb 
Fbxo15 promoter. Amplicons are numbered in order relative to their sites along the gene. 
The grey box represents an exon. Fold enrichment is the relative abundance of DNA 
fragments detected by real-time PCR at amplified region over a control amplified region. 
GST antibody was used as a ChIP control (grey). Error bars represent the s.e.m. of three 
technical replicates 
(c) 3HA-Klf2, Klf4 and Klf5 occupy Nanog promoter region in ES cells. ChIP assay was 
performed using anti-HA antibody with extract derived from ES cells ectopically 
expressed 3HA-Klf2 (blue), 3HA-Klf4 (red) or 3HA-Klf5 (green). These proteins contain 
3 copies of HA tag at the amino terminus. Control ChIP (grey) was performed using anti- 
HA antibody with extract derived from mouse ES cells. Error bars represent the s.e.m. of 
three technical replicates.  
(d) 3HA-Klf2, Klf4 and Klf5 occupy Esrrb, Fbxo15, Nanog, Tcl1 loci in ES cells. ChIP 
assay was performed using anti-HA antibody with extract derived from ES cells 
ectopically expressed 3HA-Klf2 (blue), 3HA-Klf4 (red) and 3HA-Klf5 (green). Control 
ChIP (grey) was performed with anti-HA antibody using mouse ES cells. Error bars 
represent the s.e.m. of three technical replicates. 
(e) Redundancy of Klfs at target sites. ChIP assays were performed using anti-Klf2, anti-
Klf4 and anti-Klf5 antibodies with extracts derived from ES cells transfected with control 
RNAi construct (grey bar) or ES cells transfected with Klf RNAi constructs (Klf2 RNAi, 
blue; Klf4 RNAi, red; Klf5 RNAi, green). Fold enrichment represents the abundance of 
enriched DNA fragments over a control region. GST ChIP served as mock ChIP. Data are 







3.2.4 ChIP-on-chip assay for Nanog 
Nanog was identified as an important transcription factor that is able to sustain 
pluripotency in mouse ES cells, even in the absence of LIF125, 126. As the binding profiles 
of the Klf proteins resembled that of Nanog at several known targets (such as Nanog and 
Fbxo15)40 (Figure 3.6), a Nanog ChIP-on-chip experiment was performed to compare 
the target sites of these four transcription factors.  
 
The data showed that many genes encoding key regulators bound by Klfs such as Pou5f1, 
Sox2, Nanog, Esrrb, Mycn were also bound by Nanog.  The ChIP-on-chip profiles of Klfs 
at the Nanog, Esrrb, Fbxo15, Mycn, Pou5f1 loci were identical to those obtained from 
Nanog (Figure 3.7a). The Klfs and Nanog co-occupy many common binding loci, and 
the data provide insight into the integration of the core Klf and Nanog circuitries.  
 
ChIP-on-chip analysis also revealed that Klf2, Klf4 and Klf5 bound to certain genes 
involved in cell cycle regulation, DNA replication and cell proliferation such as Cdkn1a, 
Pcna, Tcl1, and Mdm4 (Figure 3.7b). It is of interest to note that Cdkn1a (p21) is also a 
known target of Klf4 in NIH3T3 and MEF cells158. These results suggest that Klfs have 








Figure 3.7  ChIP-on-chip assay for Nanog 
(a) Co-occupied sites for Klf2, Klf4, Klf5 and Nanog at Nanog, Esrrb, Fbxo15, Mycn, 
Sox2 and Pou5f1 genes. Screen shots of the SignalMap (NimbleGen) browser showing 
Klf4 (red), Klf2 (blue), Klf5 (green) and Nanog (purple) binding at Nanog, Esrrb, 
Fbxo15, Mycn, Sox2 and Pou5f1 loci. Y axis is Log2Ratio. The peaks of Klf4, Klf2, Klf5 
and Nanog binding are highlighted by open box. Control ChIP-on-chip (black) was done 
using p53 ChIP derived DNA. Genes in mouse genome are depicted as gray boxes.  
 
(b) Klf2, Klf4 and Klf5 specific sites at Cdn1a, Pcna, Mcm4 and Tcl1 genes. Screen shots 
of the SignalMap (NimbleGen) browser showing Klf4, Klf2 and Klf5 binding at Cdkn1a, 
Pcna, Mcm4 and Tcl1 loci. Y axis is Log2Ratio. The peaks of Klf4, Klf2 and Klf5 
binding are highlighted by open box. Genes in mouse genome are depicted as gray boxes. 
 
3.2.5 Analysis of ChIP-on-chip data for Klf2, Klf4, Klf5 and Nanog 
The profiles of the three Klf proteins were strikingly similar. The overlaps between the 
genomic loci bound by all three factors were determined to be highly significant, with a P 
value of less than 0.00001. Thus, these Klfs were extensively colocalized to specific 
genomic regions (Figure 3.8). We also noted that the Venn diagram did not overlap for a 
fraction of the Klf4 and Klf5 binding loci. Although the exact nature of this difference is 
not clear, it is possible that Klf4 and Klf5 also have divergent functions and exhibit 
different binding properties at certain genomic locations. Nevertheless, our results 








Figure 3.8 Comparison between Klf and Nanog binding profiles 
(a) Venn diagram of the number of genomic loci bound by Klf2, Klf4 and Klf5. The 
diagram shows the overlap of Klf2 (blue), Klf4 (red) and Klf5 (green) binding loci in 
mouse ES cells. Of all the binding sites, 205 are the common genomic loci bound by Klf2, 
Klf4, and Klf5. The P value for the significance of the overlap is less than 0.00001 
(asterisk), as determined by the Monte Carlo permutation test.  
(b) Comparison between Klf and Nanog binding. Venn diagrams of the number of 
genomic loci bound by Klf2, Klf4, Klf5 and Nanog. These Venn diagrams show the 







3.3 Klf2, 4 and 5 bind to similar regions in the Nanog promoter  
To understand the molecular basis of the redundancy, DNA binding and transcriptional 
activation properties of the three Klfs were examined. Two Klf-binding loci were 
identified upstream of the Nanog coding region. We next investigated the role of Klf 
proteins in regulating the distal Klf-bound site that harbours enhancer activity. A series of 
6 probes were used to scan a 140 bp peak region by EMSA for direct interaction with the 
Klf proteins (Table 3.2). The DNA binding domains of each Klf were expressed and 
purified as recombinant proteins. EMSA showed that a probe was bound by all three Klf 
proteins (Figure 3.9a).  
 
Every Klf family member harbors an evolutionary conserved three-zinc finger DNA 
binding domain at the C-terminal protein. It has been shown that Klf transcription factors 
bind specifically to GC and GT box with their DNA binding domain208. A putative Klf 
motif CCCACCC was found in the positive probe.  To determine the critical nucleotides 
required for in vitro protein-DNA interactions, a series of point mutations replacing the 
CACCC sequence were introduced into the probe. EMSA revealed that mutagenesis of 
the first three nucleotides would abolish the protein-DNA interactions, while replacing 
the last two nucleotides would dramatically reduce their interactions (Figure 3.9b). A 
slight difference of binding affinities to the mutated probe may account for the different 
binding circuitries among the three Klfs in vivo.  Taken together, the data showed that the 





To address whether this site is functional in the context of an enhancer, Nanog enhancer 
genomic region including the Klf motif was cloned into the downstream of a Luciferase 
reporter containing a Pou5f1 minimal promoter. Point mutations were introduced into the 
Klf motif and wild-type or mutant enhancer constructs were transfected into ES cells. 
Luciferase assays showed that wild-type Nanog enhancer region contained enhancer 
activity and the mutations of Klf motif abolished Nanog enhancer activity to the basal 
levels, indicating the intact Klf motif is required for the function of Nanog enhancer.  
 
To reveal which Klf transcription factor is critical for Nanog enhancer activity, the Nanog 
enhancer construct was then cotransfected with shRNA expression constructs targeting 
each Klf. Knockdown of single Klf proteins did not affect the Nanog enhancer activity. 
However, depletion of Klf2, Klf4 and Klf5 by triple knockdown abolished the Nanog 
enhancer activity (Figure 3.9c). Taken together, the data showed that the Nanog 
enhancer was dependent on the Klf motif and the three Klf proteins for its activity. 
Importantly, the downregulation of Nanog enhancer activity could be reversed by 
coexpression of RNAi-resistant Klf2, Klf4 or Klf5 cDNAs (Figure 3.9d).  
 
The enhancer assay was extended to examine ten other Klf-bound regions that are not 
found at proximal promoters. Fragments of 400–500 bp were cloned downstream of a 
luciferase reporter and transfected in ES cells. Seven constructs showed enhancer 
activities with at least fivefold more activity than a control reporter without insert. Six out 
of the seven enhancers were dependent on Klf2, Klf4 and Klf5, as triple knockdown 




cDNAs rescued the downregulation of enhancer activities (Data not shown). Taken 
together, these experiments showed that the Klf2-, Klf4- and Klf5-occupied sites 
identified by ChIP may confer enhancer activity.  
 
Table 3.2 Probes for screening Klf binding site on Nanog enhancer 
Label  Sequence  
A biotin - agtccccgctccttttcagcactaaccatacaagttcatc 
B biotin - actaaccatacaagttcatcttttactcttgttttgactg 
C biotin - ttttactcttgttttgactgctaaccacccagaggaccca 
D biotin - ctaaccacccagaggacccacttaacattcctttccccac 
E biotin - cttaacattcctttccccacccacacagctagttccaacc 












Figure 3.9 Klf2, 4 and 5 bind to similar regions in the Nanog promoter  
(a) Klf2, Klf4 and Klf5 directly bind to Nanog enhancer region (red bar). EMSA was 
used to map the binding motif in the peak region of the binding profile. Double stranded 
probes (A–F) spanning 140 bp of the enhancer region were tested for DNA–protein 
interaction with the DNA binding domains of Klf2, Klf4 and Klf5.  
(b) Mutagenesis of Klf motif. A conserved motif CACCC was identified in the screen. A 
series of single or double point mutations was used to study the binding interaction of 
DNA binding domain of Klf2, Klf4 and Klf5. 
(c) Nanog enhancer is dependent on the Klf motif and the three Klfs for its activity. 
Schematic of Nanog enhancer luciferase reporter construct used to measure the effect of 
motif mutations and Klf shRNAs. The effect of Klf motif mutations on Nanog enhancer 
was tested by transfecting constructs point mutation at the Klf motif in mouse ES cells. 
Effect of Klf shRNAs on Nanog enhancer activity was tested by cotransfecting each 
RNAi construct along with the Luc-Nanog enhancer construct into mouse ES cells. 
Luciferase activity was measured at day 2 after transfection. Data are presented as the 
mean ± s.e.m. and derived from three independent experiments (n = 3). 
(d)  Rescue of Nanog enhancer activity with coexpression of RNAi-resistant Klf2, Klf4 or 
Klf5 cDNAs. RNAi-resistant Klf2, Klf4, Klf5 or Klf10 expression constructs were 
cotransfected with triple Klf2, Klf4 and Klf5 knockdown and Nanog enhancer constructs 
into mouse ES cells. Data are presented as the mean ± s.e.m. and derived from three 
independent experiments (n = 3). 
 
3.4 Gene regulation by Klf2, 4 and 5  
As concurrent depletion of the three Klf proteins by RNAi led to differentiation, DNA 
microarray experiments were performed to capture the transcriptome dynamics at 
different times after transfection of shRNA expression constructs. At day 2, the 
morphology of the ES cells depleted of Klf2, Klf4 and Klf5 was similar to ES cells 
transfected with control plasmid expressing shRNA against luciferase; these cells also 
stained positive for alkaline phosphatase. Despite maintaining these ES cell 
characteristics, the levels of ES cell-associated transcripts (such as Nanog, Tcl1, BMP4 
and Stra8) were already reduced. Expression of the ectoderm markers Fgf5, Nes and 
Cxcl12 was induced at this early time point. The data suggest that Klf2, Klf4 and Klf5 
may suppress differentiation along specific lineages. At day 4 and day 6, the Klf-depleted 




phosphatase staining. At day 6, a strong induction of the differentiation markers T and 
Cdx2 was observed in addition to a continual increase in Fgf5, Nes and Msx1 (Figure 
3.10a).  
 
Interestingly, the ChIP-on-chip data revealed a weak signal of Klf2, Klf4 and Klf5 
occupancies at the Fgf5 and Nes promoters. This binding was confirmed using ChIP–
qPCR assays (Table 3.3).  Expression analysis showed that triple knockdown of the Klf 
proteins induced higher expression than single or double knockdown (Figure 3.10b). 
However, endoderm markers (Gata4 and Gata6) were not induced, indicating that the 
cells differentiate into specific lineages.  
 
To further understand the gene regulation by Klf, the expression of selected genes was 
analyzed by RT-PCR. The expression of ES upregulated genes Nanog, Tbx3 and Esrrb 
was restored and induction of lineage marker Nes and Fgf5 was repressed by 
coexpression of RNAi-resistant Klf2, Klf4 or Klf5 cDNAs in Klf triple knockdown 
experiment (Figure 3.10c). Triple knockdown caused more change in expression 
compared to single or double knockdown (Figure 3.10d). Thus, the data shows that Klf2, 
Klf4 and Klf5 can positively regulate the expression of many self-renewal genes and 
potentially repress lineage specific genes.  
 
Recent works have generated pluripotent cell-lines from the epiblast of mouse embryos28, 
29. These epiblast stem cells (EpiSCs) are pluripotent and express ES cell markers such as 




cell-associated transcripts such as Zfp42, Dazl, Stra8 and Pecam1 and express a high 
level of Fgf5. The expression pattern of these five genes in EpiSCs is consistent with 
their profiles obtained from the triple Klf depleted ES cells. The microarray profiling data 
for different EpiSCs were obtained from published literature and we plotted the 
expression values of 30 genes in ES cells, EpiSCs and triple Klfs knockdown cells as 
heatmaps (Figure 3.10e). Interestingly, the expression of Klf2, Klf4 and Klf5 was down-
regulated in EpiSCs compared to ES cells. In addition to Zfp42, Dazl, Stra8 and Pecam1, 
the expression of Tbx3, Esrrb, Tcl1, Nr5a2, and Piwil2 was also found to be down-
regulated in EpiSCs. The levels of these transcripts were also reduced after depletion of 
the three Klfs in ES cells. 
 
Global expression profiling of ES cells and different EpiSCs reveal a group of ES cell-
specific transcripts, which are up-regulated in ES cells but not EpiSCs. A statistical 
analysis was performed to test whether the genes down-regulated by triple knockdown 
are associated with the ES cell-specific genes (defined as genes up-regulated in ES cells 
but not in EpiSC). In this test for association, the genes up-regulated in ES cells were 
divided into two groups: genes commonly up-regulated in both pluripotent cells and ES 
cell-specific genes. The former were genes being differentially up-regulated in both ES 
cells and EpiSCs as compared to differentiated cells, while the latter were genes up-
regulated only in ES cells, including the three Klfs. Depletion of the three Klfs 
downregulated 11.75% of ES cell-specific genes, but merely 3.75% of the ES cell-EpiSC 
common genes (Figure 3.10f). A p-value of 5e-20 was derived from Fisher’s Exact Test, 




cell-specific genes. The data indicate that Klf2, Klf4 and Klf5 are downregulated with a 
set of genes in EpiSCs. These genes are also downregulated upon depletion of the three 
Klfs in ES cells. We suggests that Klfs are not generally required for the maintenance of 
self-renewal of pluripotent cells such as EpiSCs and their roles may be specific to ES 
cells. The role of these Klf proteins in EpiSCs has yet to be examined. 
 
It is also of interest that the expression of Klf2, Klf4 and Klf5 are induced during early 
embryogenesis, as measured by Taqman real-time PCR assays (Figure 3.10g). The in 
vivo function of these three Klf proteins during early embryogenesis remains to be 
demonstrated. In particular, given the observation that EpiSCs are deficient in these three 
















Table 3.3 ChIP primers for Nes and Fgf5 
Nes 
Label Sense Antisense 
1 TCTACAGCTTCATTTCTTTCTTCGCCAAAC CCGCACCAGGAAAAGGAGACTAGCAAGG 
2 TTACTACCCAGGCTGGTGTCAATCCTAC AAACGGACGGTGCAGTGTTTTGTGTATAAC 
3 TGCACCGTCCGTTTTTCCAACAGTTCACGA AGACAGCCCAGAACACCCTAAGATGCAC 
4 TGATGCAGGGACCCGGGCTGTGTGTTGCAC GAAAGGGAGTAGCGGCGACAGTGACCCAG 
5 GCTTCCGCTGGGTCACTGTCGCCGCTACT CCACATCTGAAAAGATTCTTCCCCGACGCA 
6 GCTCGGGAGAGTCGCTTAGAGGTGCAGCA CCTAGGGCTTGGTTTTACCAGGGACAGGGT 
7 GATGGATGGAATTCTGAGACCTCCTAGCAC GGGCACCTTCTGATTGACAACTGCATAGT 
8 GCCCAGACAGAAGTCCCGACGTGACCAC AGGAGAGGAGATGGGTTACACAGCGGAAGA 
9 GGAACAGGACTCTGCCCTACAAAGATGTGA CCCACCTTCCAGGATCTGAGCGATCTGAC 
10 ATGTTTTTGTCTGTGATGGAGGCTTATG TTTCAAAGAACTCGAGAGCAGGTGACTGTA 
11 AGCCCGGGCCTCAGCTGTGTCTGGGGTAAG CTCAACAGTGGGACTCCAGCCGGGACCTCT 
12 CCAGAGAAGGGAAGCCAGTGAGTGTCTAGG ATCAGTTCACAAGGGATTCGGAGCTAGTC 
13 AAGGGTCCAGGCAGCTCTGAGGAATGTAAG GCTAATTATTGCCTTTTGTCCACACTACCA 
14 TAGTGTGGACAAAAGGCAATAATTAGCA TATACCCACAGATATATACTTGGTGAACCC 
15 GACTGTGTGGCTTTCATACGACAATGGTCA CTTCCAGGTGTCTGCAAGCGAGAGTTC 
16 CTCTCCTTCCACATCTTCCCTAAGCA AAACACTGTAAGTATGTCCTGACTTCACCC 
17 GCTGAAGCTGCATTTCCTTGGGATACCAG TGGGCTCTGACCTCTGCATTTTTAGGATAG 
18 ATCCTTCTCTTCCCCCTTGCCTAATACCCT GGAATGGGGGACATCCTGGGCTCTGACCTC 
 
Fgf5 
Label Sense Antisense 
1 TTCTCAGATAAATAACAGCCCCAGCATTAC CCCATGATCCGTTGCCTGGAGGAGTTAGCC 
2 GGCTCTCTAGTGGAGAAATAAACGCACACC TGTGTCCCAGCCAACTCACTCTTTACCCAG 
3 GGCGGGTGAGGGGAAGCTTCGCAGGCGTGC GCATCTTGCAGGGCTGGCTCCGGGCTCCGT 
4 AGATCACTGGCGTTATAAATATCCCGGTGC CGGGGGTCCTAAGTGCATCTTGCAGGGCT 
























































Figure 3.10 Gene regulation by Klf2, Klf4 and Klf5 
(a) Time course microarray analyses were performed to measure gene expression changes 
at different days after Klf2, Klf4 and Klf5 triple knockdown. The morphology and 
alkaline phosphatase staining are shown for each time point for both the control and Klf 
depleted cells. The scale bar represents 100 μm. Note that no difference in morphology 
and alkaline phosphatase staining was detected at day 2, indicating that the ES cells were 
undifferentiated. Microarray heatmaps depicting expression changes of selected ES cell-
associated and differentiation marker genes at different days are shown. Red indicates 
increased expression compared to control samples, whereas green means decreased 
expression. The genes expression levels were mean centred to show their relative change. 
(Done by Yuin-Han Loh and Ching-Aeng Lim) 
(b)  Klf2, Klf4, Klf5 bind to Nes and Fgf5 promoter regions and regulate their expression.  
ChIP assay was performed using anti-Klf2 (blue), anti-Klf4 (red), anti-Klf5 (green) 
antibody with extracts derived from ES cells. Schematic showing the location of the 
amplicons (black bars labeled 1-18) used to detect ChIP enriched fragment over the 6 kb 
Nes promoter and the location of the amplicons (black bars labeled1-5) used to detect 
ChIP-enriched fragment over the 1.8 kb Fgf5 promoter. Amplicons are numbered in order 
relative to their sites along the gene. The grey box represents an exon. Fold enrichment is 
the relative abundance of DNA fragments detected by realtime PCR at amplified region 
over a control amplified region. GST antibody was used as a ChIP control (grey). Error 
bars represent the s.e.m. of three technical replicates. Expression of Nes and Fgf5 is 
induced upon triple knockdown. Gene expression changes after single, double and triple 
Klfs RNAi. Quantitative real-time PCR analysis of gene expression changes after single, 
double and triple knockdown of Klf2, Klf4 and Klf5. The levels of the transcripts were 
normalized against control Luc shRNA transfection. The RNA was harvested from the 
cells at two days after transfection. Error bars represent the s.e.m. of three replicates.  
(c)  Gene expression analysis after Klf2, Klf4 and Klf5 rescue. RNAi-resistant Klf2, Klf4, 
Klf5 or Klf10 expression constructs were cotransfected with triple Klf2, Klf4 and Klf5 
knockdown construct into mouse ES cells. The expression of Nanog, Tbx3, Esrrb, Nes 
and Fgf5 was determined by quantitative real-time PCR analysis. The levels of the 
transcripts were normalized against control Luc shRNA transfection. Data are presented 
as the mean ± s.e.m. and derived from independent experiments (n = 3). 
(d) Gene expression changes after single, double and triple Klfs knockdown. Quantitative 
real-time PCR analysis of gene expression changes after single, double and triple 
knockdown of Klf2, Klf4 and Klf5. The levels of the transcripts were normalized against 
control Luc shRNA transfection. The RNA was harvested from the cells at two days after 
transfection. Error bars represent the s.e.m. of three technical replicates. Nanog, Esrrb, 
Pou5f1, Tbx3, Nr5a2, Zfp42 and Jmjd1a are up-regulated in ES cells. Nes, Fgf5, En1, 
Gata4 and Gata6 are down-regulated in ES cells. 
(e) Comparison between gene expression profiles of triple knockdown ES cells, ES cells 
and EpiSCs.  The microarray profiling data for different EpiSCs were obtained from 
published literature and we plotted the expression values of 30 genes in ES cells, EpiSCs 
and triple Klfs knockdown cells as heatmaps. The scale bar represents 100 μm. 
Microarray heatmaps (left panel) depicting expression changes of selected ES cell-
associated and differentiation marker genes at different days are shown. Microarray 




ES cells (day 2) and epiblast stem cell are shown. genes expression levels were mean 
centered to show their relative change. (Done by Ching-Aeng Lim) 
 (f) The Venn diagram shows the overlap of differentially up-regulated genes in ES cells 
and EpiSCs. DNA microarray datasets for ES cells and EpiSCs were obtained from 
literature (GEO dataset GSE7866). To obtain differentially up-regulated genes in ES cells 
(red circle) or EpiSCs (blue circle), we compared these microarray data with those 
obtained from mouse embryonic fibroblast (MEF) (GSM189664, GSM189667 of GEO 
dataset GSE7815). Statistical analysis of microarray (SAM) was used. Genes with q-
value of less than 0.01 and more than 1.5 fold change were selected. This analysis reveals 
genes specifically upregulated in ES cells (denotes as ES cell-specific) and EpiSCs 
(denotes as EpiSC-specific). The overlap represents genes commonly up-regulated in 
both pluripotent cells. A statistical test was performed to test whether the genes down-
regulated by triple knockdown are associated with the ES cell-specific genes (defined as 
genes up-regulated in ES cells but not in EpiSC). In this test for association, the genes up-
regulated in ES cells were divided into two groups: genes commonly up-regulated in both 
pluripotent cells and ES cell-specific genes. The former were genes being differentially 
up-regulated in both ES cells and EpiSCs as compared to differentiated cells, while the 
latter were genes up-regulated in ES cells only, including the three Klfs. (Done by Ching-
Aeng Lim) 
(g)  Expression within the preimplantation embryo. Embryo equivalent amounts of total 
RNA from freshly harvested embryos at the developmental stages indicated were 
analyzed for Klf2, Klf4, and Klf5 transcript levels by reverse transcription and TaqMan 
real-time PCR. TaqMan realtime PCR analysis of their expression through 
preimplantation development indicate Klf2 and Klf4 are present as maternal transcripts 
and detected throughout the preimplantation period. Klf5 expression is not detected in the 
mature oocyte but levels in the 2-cell embryo indicate dramatic and early transcriptional 
activation of this gene. Pou5f1 and Tbp were included as reference genes. Values from 
technical duplicates are expressed as fold change above background with background set 
at a threshold cycle (Ct) value of 36 and a decrease in 1 Ct calculated as a 1.9-fold 
increase in expression. E3.5 and E4.5 are blastocysts at 3.5 and 4.5 days post-fertilization, 
respectively. Real-time PCR comparison of expression levels between embryo-equivalent 
amounts of total RNA from whole blastocysts and immunosurgically dissected inner cell 
masses (ICM), both at 4.5 days post-fertilization. All three Klfs are expressed in the ICM. 
Note the lack of detection within the ICM for the TE-specific Cdx2 and virtually 
equivalent amounts of Pou5f1 between whole blastocysts and ICMs for this ICM-specific 










3.5 Klf2, Klf5 are reprogramming factors  
3.5.1 Reprogrammed cells induced by Klf2, 4, 5 
To test whether Klf2 and Klf5 also function as reprogramming factors, the standard 
reprogramming assay were performed by using fibroblasts harbouring an endogenous 
Pou5f1-GFP reporter209. Oct4 encoded by Pou5f1 is a marker that is silenced in MEFs or 
other differentiated cells and only induced at the later stage of reprogramming process. 
Reprogramming of MEFs is monitored by the reactivation of the silenced Pou5f1-GFP 
reporter (Figure 3.11a). After infection with the retroviruses, the number of GFP positive 
colonies on 14 dpi (days post infection) were quantified. Consistent with our findings on 
the functional redundancy between Klf2, Klf4 and Klf5 in ES cells, Klf2 and Klf5 in 
conjunctions with other three reprogramming factors can replace Klf4 in inducing GFP 
positive colonies that resemble ES cells and the similar result was also demonstrated in 
another independent study210 (Figure 3.11b).  
 
Klf2 showed relative higher reprogramming ability compared to Klf4 according to the 
number of GFP positive colonies. However, the number of GFP positive colonies 
generated using Klf5 was much lower than Klf4 by introduction together with Oct4, Sox2 
and c-Myc. The similar results are obtained from an independent study210. The reason for 
the lower efficiency of reprogramming by Klf5 compared to Klf4 is not clear. Amino-
acid sequence alignment of DNA binding domains has revealed greater structural 
similarities between Klf2 and Klf4 (Figure 3.11c), and may explain the stronger 
functional redundancies of these two family members in reprogramming. We also noted 




is possible that Klf4 and Klf5 may exhibit different binding properties at certain genomic 
locations and have divergent functions. Our RNAi knockdown, ChIP-on-chip, reporter 
assay and EMSA results strongly indicate that Klf2, 4, 5 show a redundant role in 














Figure 3.11 Identification of Klf2 and Klf5 as a reprogramming factor 
(a) Reprogrammed cells induced by defined factors from the MEFs harboring an 
integrated Pou5f1- GFP reporter. Bright field image is shown. GFP positive signal 
indicates that the expression of endogenous Pou5f1 was restored specifically in the 
reprogrammed cells, but not in the surrounding fibroblasts. The scale bars represent 200 
μm.  
(b) Candidate factors were screened by co-transduction with Oct4, Sox2 and c-Myc in 
Pou5f1-GFP MEFs. At 14 dpi, the number of GFP-positive colonies was recorded and 
used as an indicator of reprogramming efficiency. The results of two independent 
experiments are shown.  
(c) DNA binding domain similarity tree of Klf2, 4, 5 and10. DNA binding domains of 




3.5.2 Validation of Klf2 reprogrammed cells 
MEFs with GFP under the control of a constitutively active actin promoter were used for 
the standard reprogramming assay. Constitutive expression of GFP allows us to trace 
these cells in the microinjection assays. Klf2 or Klf5, with Oct4, Sox2 and c-Myc, was 
able to induce the formation of ES-like cells that stained positive for alkaline phosphatase 
(Figure 3.12a). However Klf10, another Klf family member could not produce the ES-
like cells.  
 
As it has been demonstrated that c-Myc is not essential for reprogramming210, 211, actin-
GFP MEFs were transduced with Oct4, Sox2 and Klf2 (OSK2), and ES-like cells could 
be obtained. The established OSK2 line was expressing similar Oct4, Sox2, Nanog and 
Zfp42 levels compared to one ES cell line (Figure 3.12b). Nakagawa et al. showed that 
Klf2 can replace Klf4 in inducing iPS cells which are able to give rise to teratomas in 
nude mice210.   
 
To further validate the pluripotency of Klf2 reprogrammed cells, in vivo test was carried 
out. After injection into 8-cell embryos, the OSK2 reprogrammed cells contributed 
extensively to the resulting chimeric mouse embryos, as the E9.5 embryos showed 
widespread incorporation of GFP-labelled cells (Figure 3.12c). Immunohistochemical 
analysis demonstrated that chimeric embryo contained GFP positive cells which were 
widely and extensively distributed among all tissues and organs and were represented in 
tissues derived from all three major germ layers (ectoderm, mesoderm and endoderm) of 





Further studies need to be carried out to determine whether these OSK2 reprogrammed 
cells can contribute to the germ lineage and show germline transmission. Taken together, 










Fiugre 3.12 Klf2 reprograms MEFs with Oct4 and Sox2.  
(a) Alkaline phosphatase expression in Klf2 and Klf5 reprogrammed cells. 
(b) Quantitative real-time PCR analysis of gene expression of Oct4, Sox2, Nanog and 
Zfp42 in Klf2 reprogrammed cells. The levels of the transcripts were normalized against 
two control MEFs (129 and CD1). Error bars represent the s.e.m. of three technical 
replicates. 
(c)  Embryos derived from the 8-cell stage embryos injected with Klf2 reprogrammed 
cells are shown. The embryos were collected at E9.5. GFP fluorescence images for the 
embryos shown (right two panels). The embryos were observed directly under stero-
microcope for GFP expression. Wild-type embryo shows no GFP fluorescence (upper 
panes). 
(d) Immunohistochemical analysis of parasagittal sections to show the distribution of 
GFP-positive cells in embryo. The section was probed with anti-GFP antibody (B-2, 
Santa Cruz) and counterstained with haematoxylin. Abbreviations: F, forebrain; Fg, 
foregut diverticum; H, heart, Hb, hindbrain; M, midbrain; Ne, neuroepithelium; O, otic 
vesicle; S, somite. (Done by Lai-ping Yaw) 
 
 
3.6 Integration of the core Klf circuitry with the Nanog transcriptional regulatory 
network  
Klf2, Klf4 and Klf5 are shown to be functionally redundant and they exhibit similar 
binding properties in ES cells. Collectively, the bound targets of these Klf proteins 
constitute the core Klf circuitry. The Klfs and Nanog co-occupy many common binding 
loci, and the data provide insight into the integration of the core Klf and Nanog circuitries 
(Figure 3.13a).  
 
Klf2, Klf4 and Klf5 are coordinately upregulated in ES cells, thereby permitting the 
expression of a subset of ES cell-specific genes. As each Klf was observed to bind to 
their respective gene, the coordinated regulation of Klf proteins may, in part, be mediated 
through autoregulatory loops commonly found among key regulators in ES cells (Figure 
3.13b). The data also show that these regulators form a highly interconnected 




regulatory loci of Nanog by transcription factors important to maintain ES cells (Figure 
3.13c). Although our study only investigated the roles of Klf2, Klf4 and Klf5, it is 















Figure 3.13 transcriptional regulatory network in ES cells  
(a) Schematic representation of a model for the transcriptional regulatory network 
targeted by Klf2, Klf4, Klf5 and Nanog. Klf2, Klf4 and Klf5 target genes involved in 
DNA replication and selfrenewal are shown. Common targets of Klfs and Nanog are 
genes required for self-renewal and maintenance of pluripotency of ES cells (red boxes). 
(b) Autoregulatory loops formed by different transcription regulators in ES cells. The 
genes are presented in the open boxes and transcription factors are represented by ovals. 
Oct4, Sox2, Nanog and Sall4 have previously been shown to have autoregulatory 
configurations.  
(c) Regulatory regions of Nanog receive multiple inputs. Two key regulatory regions 
(enhancer and proximal promoter) are shown as red and orange bars, respectively. Klf2, 
Klf4 and Klf5 direct bind to Nanog enhancer. The Nanog enhancer is also targeted by 















CHAPTER IV DISCUSSION  
4.1 Klf4, Klf2 and Klf5 have diverse functions in cell proliferation and 
differentiation and animal development  
The critical functions of Klf4, Klf2 and Klf5 are indicated in many studies. Klf4 can 
serve as a tumor suppressor or an oncogene in a context-dependent manner212. Forced 
expression of Klf4 in cultured cells results in the inhibition of DNA synthesis and cell 
cycle processes158, 213. Klf4 null mice die shortly after birth and show an impaired 
differentiation in the skin and in the colon147, 148. Loss of Klf4 causes altered proliferation 
and differentiation and precancerous changes in the adult stomach of mice214. Within the 
hematopoietic system, Klf4 is a critical regulator in the transcriptional network 
controlling monocyte differentiation215. These results indicate that Klf4 plays a crucial 
role in cell proliferation and differentiation.  
 
Klf4 is shown to be a downstream target of LIF signaling pathway in ES cells as its 
expression is rapidly induced by supplement of cytokine LIF and the inactivation of Stat3 
markedly decreases Klf4 expression161, 185, 216. Ectopic expression of Klf4 in ES cells 
promotes their capacity to self-renew based on secondary embryoid body (EB) formation 
and restored expression of Oct4161. Interestingly, Klf4 overexpression supports ES growth 
in the absence of LIF162, 216. This function may link to Nanog as overexpression of Nanog 
enables ES cells to undergo self-renewal in the absence of LIF125, 126.  
 
Klf5 is shown to be a mediator of mouse fibroblast cell proliferation in the various in 




pathway217, 218. In acute lymphoblastic leukemia, KLF5 interacts with tumor suppressor 
p53 in regulating the expression of the inhibitor-of-apoptosis gene survivin, which may 
play a role in pathological process of cancer219. The expression of KLF5 is lower and 
deletion of KLF5 is often detected in various breast cancer cell lines220. KLF5 is 
frequently deleted and down-regulated but rarely mutated in prostate cancer221. These 
results indicate Klf5 play roles in tumor progresses. Klf5 also play diverse roles in the 
development of many tissues. Klf5 is shown to play a pivotal role in the pathogenesis of 
cardiovascular disease as Klf5+/- mice show diminished levels of arterial-wall thickening, 
angiogenesis, cardiac hypertrophy and interstitial fibrosis in response to injury149. 
Neonatal heterozygous Klf5 knockout mice exhibit a marked deficiency in white adipose 
tissue development, suggesting that Klf5 is also required for adipogenesis222. Transgenic 
mice conditionally deleted Klf5 in respiratory epithelial cells die of respiratory distress 
immediately after birth, indicating Klf5 is required for perinatal lung morphogenesis and 
function223.  
 
Klf5 null embryos fail to implant due to defects in trophectoderm development and die 
before E6.5 days149, 224. The expression of Klf5 initiates at the 2 cell-stage, and Klf5 
protein is detected in both ICM and trophoblast. Cdx2, an important transcription factor 
required for trophoblast development, is downregulated in Klf5 knockout embryos which 
probably accounts for the abnormal phenotype in early embryo development. Klf5 -/- ES 
cells can not be derived from Klf5 knockout ICM cells directly, but can be established 




of mouse ES cells for LIF224.  These results indicate Klf5 have specific functions in early 
embryo development and ES cell self-renewal.  
 
Klf2 is expressed in lung, endothelial cells and lymphocytes, and is essential for normal 
blood-vessel integrity and lung development145, 225, 226. Deficiency in Klf2 leads to a 
massive loss of the peripheral T-cell pool, suggesting Klf2 regulates T-cell quiescence 
and survival145. Klf2-deficient thymocytes also show impaired expression of several 
receptors required for thymocyte emigration and peripheral trafficking, indicating Klf2 is 
essential for T-cell trafficking227. Klf2 null ES cells grow normal in spite of their derived 
MEF cells having adipogenesis defects228. Klf2 also is shown to support LIF-independent 
self-renewal162.   
 
Although Klf2, Klf4 and Klf5 have the diverse roles in cell proliferation and 
differentiation, and animal development, their detailed roles in ES cells are not 
appreciated.  
 
4.2 Redundancy between family members  
To study the roles of Klf members in the stem cells, we use a combination of different 
assays. We show that Klf4 alone is dispensable for the self-renewal state of ES cells, 
while a group of Klfs, including Klf2, Klf4 and Klf5, are required for maintaining the 
undifferentiating state of ES cells. Simultaneously triple depletion of these three Klfs 
leads to differentiation, and this phenotype can be rescued by any of the three Klfs, 




mechanisms under the phenotype, ChIP-on-chip analysis is performed and reveals that 
the binding profiles of Klf2, Klf4 and Klf5 are strikingly similar. In another genomic-
wide mapping study, about 41.9% of Klf4 binding loci with multiple transcription factor 
binding loci (MTL) are associated with binding of core transcription factors Oct4, Sox2 
and Nanog113. For the three Klf common binding locus in Nanog enhancer region, Klf2, 
Klf4 and Klf5 bind to the same motif and all three Klfs are required for the enhancer 
activities. The expression of Klf2, Klf4 and Klf5 is enriched in ES cells and highly 
associated with that of many important self-renewal and pluripotent regulators, such as 
Nanog, Esrrb, Tcl1, and Tbx3. These results highlight that Klf2, Klf4 and Klf5 are 
required to maintain the unique transcriptional regulatory network and expression 
program for ES cells.  
 
Our results demonstrate the functional redundancy between Klf2, Klf4 and Klf5 in ES 
cells. There are some clues indicating their possible redundant functions. The expression 
of all three Klfs is highly upregulated in ES cells, and downregulated upon the 
differentiation.  The expression of three Klfs is induced during the early development and 
shows a similar pattern to Oct4 induction. The DNA binding domains of these three Klfs 
are conserved and highly similar which indicate they can bind to similar DNA sequence. 
All three Klfs are shown to support LIF-independent self-renewal of ES cells when 
ectopicly expressed162, 224.  
 
The family members have been shown to play redundant roles for each other in some 




in development. When c-Myc coding sequences are replaced with n-myc coding 
sequences, n-Myc is capable of replacing most of the essential c-Myc functions required 
for embryonic development and for proliferation of differentiated cells229. The different 
physiological roles of c-Myc and n-myc relate primarily to differences in transcriptional 
regulation of the genes and their spatial and temporal expression, rather than distinct 
biochemical properties of the n-Myc and c-Myc proteins.  
 
The redundancy issues are not be widely explored in the stem cell field. The core 
circuitry of stem cell intrinsic transcriptional regulatory network are shown to be 
indispensable as Oct4, Sox2 and Nanog play unique roles in maintaining the self-renewal 
and pluripotent state of ES cells.  Knockout or depletion of any of them causes early 
embryo development defect in vivo or impairment of self-renewal and pluripotency in 
vitro40, 99, 102, 120, 124, 126. The Oct or Sox family has several members respectively.  
However, their possible redundancy roles in the early development and ES cells have not 
been appreciated. Apart from the core trinity factors, other factors also have been shown 
to guard the unique properties of ES cells, including Zfp143, Esrrb, and Sall4.  The study 
of redundant roles of family members, especially through loss-of-functions, is hindered 
by many factors, such as the difficulty of raising the reagents, time-consuming 
experiments and unknown functional correlation between different family members. 
 
The redundant function between different Klf family members was also tested by factor-
induced reprogramming experiments whose results showed that Klf1, Klf2 or Klf5 can 




factors, Oct4, Sox2 and c-Myc210. The redundant functions are largely explored, 
especially in reprogramming. c-Myc can be replaced by n-Myc or l-myc210, 230. Sox2 is 
shown to be substituted by several family members, such as Sox1, Sox3210. We 
independently show that Klf4 can be replaced by Klf2 or Klf5 in a reprogramming 
assay231. However, all these reprogramming experiments are gain-of-function analysis 
which means that one of family members will sufficiently accomplish the required 
biological functions.  
 
It is of interest that the expression of Klf2, Klf4 and Klf5 is induced during early 
embryogenesis, as measured by a Taqman real-time PCR assay.  The in vivo function of 
these three Klf proteins during early embryogenesis remains to be demonstrated. The 
multiple knockout of Klf2, Klf4 and Klf5 experiment will provide us more valuable 
information on their functions.  It is interesting to know whether these three Klf can 
functionally replace each other in vivo. The knockin studies can be performed to elucidate 
this issue.  
 
The functional redundancy can also be satisfied by different family members.  When 
introduced into Sox2 deficient ES cells, Oct4 is shown to rescue the Sox2 null caused 
differentiation phenotype124. A possible explanation is the key role of Sox2 is to maintain 
the expression of Oct4 in pluripotent ES cells. Nanog overexpression can substitute for 
the depletion of Esrrb, Tbx3, Tcl1, or Dppa4 probably through compensatory 
upregulation of other self-renewal components132. ES cells with overexpression of Ronin 




suggest that complex interconnected transcriptional regulatory networks or protein 
interaction networks are integrated to form a unique framework in maintaining the self-
renewal of ES cells. The loss of some components can be substituted by compensational 
expression of functionally redundant family members or other regulators.  
 
4.3 The reprogramming process and reprogramming factors 
Successful reprogramming approaches such as SCNT and cell fusion indicate that 
oocytes or embryonic stem cells harbor key factors that can induce pluripotency. It seems 
that these factors also play important roles in the maintenance of pluripotency. Based on 
this hypothesis, 24 candidate factors were selected for testing in a reprogramming assay. 
The results show that retrovirus introduction of four transcription factors, Oct4, Sox2, c-
Myc and Klf4, is sufficient to induce ES-like cells from somatic mouse fibroblast cells56. 
Further studies confirm that these induced pluripotent stem (iPS) cells are similar to ES 
cell and fulfilled the entire criteria tests for authentic pluripotent cells58, 232, 233. Apart 
from fibroblasts, B lymphocytes, hepatocytes and gastric epithelial cells can also be 
converted to iPS cells using the same four transcription factors234, 235. iPS cells are tested 
to be able to correct the genetic disease in mice and give rise to specialized cell types, 
indicating their promising practical applications in regenerative medicine197.  
 
Among the four reprogramming factors, c-Myc is shown to be a downstream target of 
LIF signaling pathways to promote the self-renewal of ES cells166. However, c-Myc is 
shown to be dispensable in forming the iPS cells and the omission of the c-Myc 




are critical for the pluripotent state of cells in vitro and in vivo and are indispensable in 
generating iPS cells from somatic cells. Neural stem cells endogenously express Sox2, c-
Myc, and Klf4 as well as several intermediate reprogramming markers, thus Oct4 alone is 
sufficient to produce the pluripotent stem cells despite the efficiency being much lower 
compared with the two factors (Oct4-Klf4 or Oct4-cMyc)236. However, Oct4, Sox2, and 
Klf4 are still the indispensable factors for inducing authentic pluripotency from mouse 
somatic cells.  
 
Human iPS cells can be derived by transduction of Oct4, Sox2, Klf4 and c-Myc or Oct4, 
Sox2, Nanog and Lin28 into human somatic cells232, 237. In fact, Oct4 and Sox2 are 
sufficient to generate human iPS cells and other factors are able to increase the efficiency 
of induction. However, it is argued that human iPS cells and human ES cells are equal to 
their mouse counterparts due to the lack of stringent tests of pluripotency in vivo for 
human cells.  Evidence has been shown that human ES cells are more akin to mouse 
EpiSCs which are derived from post-implantation embryos. EpiSCs differ from ES cells 
by upregulation of the postimplantation markers Fgf5 and T 28, 29. Female EpiSCs, but not 
ES cells, contain a silent X chromosome which is a definite epigenetic distinction 
between early and late epiblast. Recently, Guo et al reported that when cultured in 
EpiSCs conditions, mouse ES cells can readily differentiate to EpiSCs. Interestingly, 
when introduced with Klf4 and cultured in ground stage conditions, EpiSCs can generate 
iPS cells which are referred to as EpiSCs-iPS cells. These cells are able to generate high-
contribution chimaeras that yield germline transmission, indicative of authentic 




pluripotent state. The detailed roles of Klf4 to build up the unique transcriptional 
regulatory network and reset the epigenetic landmarks specific for ES cells still need to 
be explored. It is also of interest to know whether Klf2 and Klf5 show similar functions.  
 
The detailed mechanisms of reprogramming factors that build up pluripotency in somatic 
cells are not clear. It seems that the reprogramming process by defined transcription 
factors is different from traditional approaches such as SCNT and cell fusion. During iPS 
cell generation, exogenous reprogramming factors are required for about 10 days. 
Upregulaiton of alkaline phosphatase and stage-specific embryonic antigen 1 (SSEA1) 
occur at early time points. Expression of endogenous Oct4, Sox2, Nanog genes and 
reactivation of the silent X chromosome, marking fully reprogrammed cells, is only 
observed late in the process238, 239. These results suggest that transcription factor-induced 
reprogramming is a gradual process. It is shown that reprogramming of the somatic cell 
genome begins during the first cell cycle after the fusion of a somatic cell with a 
pluripotent cell. Reactivation of Oct4-GFP transgene expression is detected on day 2 
(around 44–48 hours) after fusion of embryonic stem (ES) cells with neurosphere cells240, 
241. The transfer of the genome of a differentiated cell into an unfertilized oocyte 
transforms the transcriptional program of the somatic cell into an embryonic 
transcriptional program in a remarkably short time period. This may come from the 
difference that cell fusion and SCNT can take advantage of the presence of all players in 
a complex network, whereas factor-induced reprogramming must start up to induce other 





4.4 Klf and Esrrb are functionally related  
According to the global expression analysis of Klfs RNAi, many important pluripotent 
genes are shown to be regulated by Klfs, such as Nanog, Esrrb, and Tcl1. The rescue 
experiment shows that Esrrb is able to rescue the differentiation phenotype induced by 
Klf triple RNAi on ES cells. Esrrb is a direct downstream target of Klf2, Klf4 and Klf5 
as these three Klfs bind to Esrrb gene in ChIP assays and expression of Esrrb is 
correlated with those of Klfs.  Esrrb also positively regulates many key self-renewal 
regulators such Sox2, Nanog, Tcl1, Tbx3 which are also targets of Klfs. Interestingly, 
expression of Klf4 and Klf5 decreases with the depletion of Esrrb. Esrrb binds to Klf4 and 
are responsible for the activity of the regulatory element231. These results strongly 
indicate there is a reciprocal regulation between Esrrb and Klf transcription factors in ES 
cells which may explain the substitutionary functions between Klf4 and Esrrb in 
reprogramming. 
 
Genomic location analysis showns that Esrrb shares many of its targets with those of Klf4 
which indicates Esrrb may directly substitute the functions of Klfs in ES cells. However, 
the exact function of Klfs and Esrrb in the reprogramming should be investigated further. 
To dissect the functions of Klfs and Esrrb, the knockout Klf2, Klf4, Klf5 or Esrrb cells 
need to be examined in the process of reprogramming. Due to our previous results 






In the reprogramming screening experiments, we showed that Klf4 can be substituted by 
Esrrb in inducing reprogrammed cells. The Esrrb reprogrammed cells has been confirmed 
to be pluripotent as ES cells by all the stringent tests in intro and in vivo analysis. To our 
knowledge, this is first time shown in the mouse system that exogenous Klf4 is not 

























































CHAPTER V CONCLUSIONS 
 
Mouse ES cells belong to pluripotent stem cells which are invaluable tools and models to 
study diseases, development and regenerative therapy19. Recently, the successful 
derivation of pluripotent cells by defined factor-induced reprogramming from somatic 
cells makes the generation of patient-specific pluripotent stem cells in the near future 
look very promsing56, 232. The elucidation of functions of reprogramming factors in ES 
cells will provide more insights for our understanding of maintenance and recapture of 
pluripotency. To reveal the role of Klf4 and Klf family members in maintaining unique 
property of ES cells, different assays were carried out.  
 
This project has revealed the critical roles of Klf2, Klf4 and Klf5 in the maintenance of 
ES cell self-renewal. RNAi was performed to deplete its expression in ES cells to dissect 
the functions of Klf4. No change in morphology and alkaline phosphatase staining was 
observed after Klf4 knockdown, indicating that Klf4 alone is not required for the normal 
ES cell growth. Two other Klf family members, Klf2 and Klf5, were found to be enriched 
in ES cells and downregulated during differentiation. Depletion of either Klf2 or Klf5 
also showed no effect on ES cell self-renewal. Double knockdown of any two of the three 
Klfs did not induce ES cell differentiation. Simultaneously triple depletion of all three 
Klfs induced the loss of typical ES cell morphology and specific alkaline phosphatase 
staining, a characteristic of ES cell differentiation. The differentiation phenotype induced 
by triple Klf knockdown could be rescued by any RNAi-resistant Klf2, Klf4 and Klf5 
cDNA, indicating the three Klfs are playing a redundant role in maintaining the 




shown to suppress the differentiation and support the LIF-independent ES self-renewal, 
we were the first to demonstrate that the three endogenous Klf family members, Klf2, 
Klf4 and Klf5, are critical for ES cell self-renewal.  
 
To investigate the molecular mechanisms of redundancy for Klf2, Klf4 and Klf5 in ES 
cells, ChIP-on-chip was carried out by using the specific Klf antibodies and custom-
designed genomic tiling microarrays. ChIP-on-chip results showed that the binding 
patterns of Klf2, Klf4, and Klf5 were prominently similar and these three Klfs shared a 
significant portion of common binding loci, indicating that these three Klfs collaborate to 
regulate common target genes. Klf2, Klf4 and Klf5 were shown to co-occupy many self-
renewal and pluripotent regulators, such as Nanog, Esrrb, and Tcl1.  More importantly, 
the other two Klfs were bound to the target sites when one of them was depleted.  Klfs 
also have a portion of co-occupied binding sites with Nanog, suggesting the integration of 
the core Klfs and Nanog transcriptional regulatory networks.  
 
To further understand the molecular basis of redundancy, the DNA binding and 
transcriptional activation properties of the three Klfs were validated by examining the 
Nanog enhancer region. EMSA results showed there contains a Klf motif in Nanog 
enhancer region and the same motif was bound by recombinant Klf2, Klf4 or Klf5 DNA 
binding domain. The intact binding motif and three Klf proteins were required for Nanog 
enhancer activity tested by reporter assay. Consistent with the differentiation phenotype 
induced by triple Klf RNAi, DNA microarray showed that many self-renewal and 




upregulated upon the suppression of the expression of the three Klf genes. Any of the 
three Klf factors were able to rescue the expression of selected markers. Taken together, 
these results highlight that Klf2, Klf4 and Klf5 form a close alliance to sustain the ES cell 
state. The impact of losing one of them is masked by the other two family members.  
 
The functional redundancy among Klf2, Klf4 and Klf5 was also confirmed by a factor-
induced reprogramming assay. Consistent with an independent observation210, Klf2 and 
Klf5 were able to substitute Klf4 to generate reprogrammed cells in the conjunction with 
the other three reprogramming factors, Oct4, Sox2 and c-Myc. Klf2 reprogrammed cells 
were incorporated extensively in the chimeric embryo. These results indicate these three 
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List of genes and their coordinates on the custom designed microarray 
Chromosome mm5 coordinates Gene(1) Gene(2) 
chr1 chr1:4453577-4559061 Sox17  
chr1 chr1:15917437-16055202 Terf1  
chr1 chr1:52332580-52575344 Stat1 Stat4 
chr1 chr1:63046252-63258435 Nrp2  
chr1 chr1:64380327-64566045 Klf7  
chr1 chr1:72682489-72873479 Xrcc5  
chr1 chr1:73208897-73359173 Igfbp2 Igfbp5 
chr1 chr1:75608366-75712623 Tuba4  
chr1 chr1:78507003-78701663 Pax3  
chr1 chr1:89786448-89889662 Gbx2  
chr1 chr1:118338416-118495209 Tcfcp2l1  
chr1 chr1:120326028-120431347 En1  
chr1 chr1:132022652-132122652 miR135b  
chr1 chr1:134400020-134573652 Jarid1b  
chr1 chr1:136462843-136566187 Zfp281  
chr1 chr1:136682175-136901392 Nr5a2  
chr1 chr1:151381520-151513029 Rnf2  
chr1 chr1:167669829-167924518 Lmx1a  
chr1 chr1:179719335-179839315 Elys  
chr1 chr1:180716861-180820845 Mixl1  
chr1 chr1:180918897-181025242 Lefty2  
chr1 chr1:189937294-190086198 Prox1  
chr1 chr1:194880944-194980944 miR29b-2,29c  
chr2 chr2:9758958-9878902 Gata3  
chr2 chr2:25969030-26132803 Btbd14a  
chr2 chr2:29972065-30081814 Set  
chr2 chr2:38261575-38379579 Lhx2  
chr2 chr2:38636905-38936411 Gcnf  
chr2 chr2:51982823-52132047 Rif1  
chr2 chr2:57010885-57127288 Nurr/Nr4a2  
chr2 chr2:71373611-71478146 Dlx1  
chr2 chr2:72780814-72923763 Sp3  
chr2 chr2:105518674-105640073 Pax6  
chr2 chr2:113778865-113884388 actin alpha  
chr2 chr2:120929828-121102278 Trp53bp1  
chr2 chr2:121846710-121952105 B2m  
chr2 chr2:126252166-126387265 Slc27a2  
chr2 chr2:130987118-131087118 miR103-2  
chr2 chr2:131948310-132052188 Pcna  




chr2 chr2:145924800-146026594 Insm1  
chr2 chr2:146880109-146988816 Nkx2.2  
chr2 chr2:147745484-147849530 Foxa2  
chr2 chr2:152156958-152262443 Tcf15  
chr2 chr2:152749605-152850755 Id1  
chr2 chr2:153662806-153801075 Dnmt3b  
chr2 chr2:154572987-154683201 E2f1  
chr2 chr2:157573480-157675797 Nnat  
chr2 chr2:157750811-158004963 Ctnnbl1  
chr2 chr2:164087501-164268872 Stk4  
chr2 chr2:165668411-165884743 Eya2  
chr2 chr2:167505758-167655922 Zfp313 Snai1 
chr2 chr2:168761454-168863088 Sall4  
chr2 chr2:172562732-172671727 Tcfap2c  
chr2 chr2:174284552-174384552 miR296  
chr2 chr2:179963340-180072880 Gata5  
chr2 chr2:180296171-180440307 Dido1  
chr2 chr2:180532282-180632282 miR124a3  
chr2 chr2:181307962-181409744 Sox18  
chr3 chr3:17397574-17497574 miR124a2  
chr3 chr3:26811411-26968571 Ect2  
chr3 chr3:32066873-32197695 Wig1  
chr3 chr3:32441932-32560177 Actl6a  Baf53a-pending 
chr3 chr3:34402927-34505331 Sox2  
chr3 chr3:36316610-36423682 Cyclin A2  
chr3 chr3:37172037-37430829 Spaf-pending  
chr3 chr3:41258650-41418305 Phf17  
chr3 chr3:52302398-52482354 Foxo1  
chr3 chr3:54825115-54940261 Smad8  
chr3 chr3:88410785-88520099 Nestin  
chr3 chr3:89793593-89904993 Shc1  
chr3 chr3:90864641-90966901 Nf45  
chr3 chr3:95268308-95401938 Eset  
chr3 chr3:99127398-99327786 Tbox15  
chr3 chr3:116007205-116111813 Edg1  
chr3 chr3:127975356-128165308 miR302 Ngn2 
chr3 chr3:129695993-129801603 Pitx2  
chr3 chr3:131643385-131857096 Lef1  
chr3 chr3:138372195-138474516 H2A histone  
chr4 chr4:54722188-54827228 Klf4  
chr4 chr4:56029036-56183287 Catnal1  
chr4 chr4:72476250-72658007 Jmjd2c  
chr4 chr4:84881156-84993015 Adrp  
chr4 chr4:93329330-93432462 Jun  




chr4 chr4:97936574-98038897 FoxD3  
chr4 chr4:98045677-98209393 Itgb3bp  
chr4 chr4:98225534-98383039 Pgm2  
chr4 chr4:115391997-115510472 Ptch2  
chr4 chr4:116433957-116575647 Jmjd2a  
chr4 chr4:121316414-121422793 Lmyc1  
chr4 chr4:132004453-132105199 Mkrn3  
chr4 chr4:132251917-132392374 Rps6ka1  
chr4 chr4:132407956-132523442 Lin28  
chr4 chr4:134551837-134702729 Id3 E2f2 
chr4 chr4:134958574-135110725 Aof2  
chr4 chr4:144356021-144806143 Rex2  
chr5 chr5:4760451-5436916 Pftk1  
chr5 chr5:25154786-26162667 Dpp6  
chr5 chr5:26805325-26915572 Shh  
chr5 chr5:27887082-27987662 Dppa5  
chr5 chr5:30967903-31142020 Yes  
chr5 chr5:32734344-32851366 Rnf4  
chr5 chr5:52166672-52332152 Rbpsuh  
chr5 chr5:65648456-65751938 Phox2b  
chr5 chr5:73721071-73928966 Gsh2 Pdgfra 
chr5 chr5:75769147-75897339 Hod  
chr5 chr5:75951660-76068600 Rest  
chr5 chr5:89251072-89369184 Afp  
chr5 chr5:95523937-95645077 Fgf5  
chr5 chr5:101754477-101860387 Spp1  
chr5 chr5:105457444-105599471 Mtf2  
chr5 chr5:112309606-112432182 Tcf1  
chr5 chr5:112844811-112951001 SIRT4  
chr5 chr5:117106216-117218017 Tbx3  
chr5 chr5:117271565-117420164 Tbx5  
chr5 chr5:117873981-117984167 Lhx5  
chr5 chr5:140333848-140437454 Beta-actin  
chr5 chr5:144544959-144682045 Pdx1 Cdx2 
chr6 chr6:6539624-6658041 Dlx6 Dlx5 
chr6 chr6:28824844-28924844 miR129-1  
chr6 chr6:30533166-30733385 Mest  
chr6 chr6:30890068-30990068 miR29a,29b-1  
chr6 chr6:39275681-39398292 Mkrn1  
chr6 chr6:52052653-52301941 whole Hoxa  
chr6 chr6:56739854-56886810 Fkbp9  
chr6 chr6:65097702-65269284 Etl1  
chr6 chr6:67097607-67200124 Gadd45a  
chr6 chr6:71766586-71910113 Jmjd1a  




chr6 chr6:88129862-88237773 Cnbp1  
chr6 chr6:88478258-88591605 Gata2  
chr6 chr6:89171092-89286482 Mcm2  
chr6 chr6:97510667-97632275 Ube1c  
chr6 chr6:100559568-100717648 Rybp  
chr6 chr6:109000683-109106767 Stra13  
chr6 chr6:113512025-113626609 Rosa26  
chr6 chr6:120713755-120868801 Jarid1a  
chr6 chr6:122899306-123021209 Edr1  
chr6 chr6:123133071-123434300 Nanog cluster  
chr6 chr6:125728777-125832529 AK002273  
chr6 chr6:127710276-127831972 Ccnd2  
chr6 chr6:128968032-129079234 FoxM1  
chr6 chr6:137524744-137797510 Eps8  
chr6 chr6:143932355-144410309 Sox5  
chr6 chr6:148331390-148638842 Rps4y2  
chr7 chr7:3260406-3399839 Nalp4c  
chr7 chr7:17685464-17807436 SIRT2  
chr7 chr7:23486833-23589548 Cebpa  
chr7 chr7:32321968-32431551 Prmt1  
chr7 chr7:32561111-32679291 Tead2  
chr7 chr7:47037038-47159141 SNRPN-Snurf  
chr7 chr7:49275003-49376576 Ndn  
chr7 chr7:57342749-57449900 Nr2f2  
chr7 chr7:67487870-67668101 Blm  
chr7 chr7:77078806-77205096 Eed  
chr7 chr7:91310192-91411687 Hbb  
chr7 chr7:97281577-97415309 Zfp143  
chr7 chr7:126478778-126597310 Bnip3  
chr7 chr7:127545941-127647197 Utf1  
chr7 chr7:128503267-128621436 SIRT3  
chr7 chr7:130228405-130439374 Igf2/H19  
chr7 chr7:130621598-130723999 Ascl2  
chr7 chr7:132516903-132622712 Fgf4  
chr7_random chr7_random:7029230-7130282 Zfp296  
chr7_random chr7_random:10040039- ZEC  
chr7_random chr7_random:17561914- Zfp110  
chr7_random chr7_random:20793562- Peg3  
chr7_random chr7_random:43614382- Tif1b  
chr8 chr8:12361556-12462746 Sox1  
chr8 chr8:21079639-21200812 Slc25a15  
chr8 chr8:24543666-24669438 Ash2l  
chr8 chr8:42363594-42475497 Zfp42  
chr8 chr8:56055840-56159374 Hand2  




chr8 chr8:71301373-71403587 Klf2  
chr8 chr8:76732518-76894301 Ednra  
chr8 chr8:77498417-77600761 Pou4f2  
chr8 chr8:78411507-78572446 Smad1  
chr8 chr8:79825439-79941942 Smarca5  
chr8 chr8:83893115-84096623 Nac1 Nfix 
chr8 chr8:84202476-84304243 JunB  
chr8 chr8:88292659-88406860 Sall1  
chr8 chr8:91070548-91173261 Irx3  
chr8 chr8:104900005-105046440 Ctcf  
chr8 chr8:106161852-106284099 Tex292  
chr8 chr8:107977057-108321141 Atbf1  
chr8 chr8:115910107-116174268 Cdyl2  
chr8 chr8:122828683-122939128 Tubb3  
chr8 chr8:123135303-123265303 Rab4a  
chr8 chr8:127730554-127974781 Nrp1  
chr9 chr9:20784672-20929794 Dnmt1  
chr9 chr9:21456980-21577004 Carm1  
chr9 chr9:23117838-23486710 Bmper  
chr9 chr9:32360361-32578018 Fli1  
chr9 chr9:57946016-58089739 Arid3b  
chr9 chr9:63833000-64044100 Smad3  
chr9 chr9:64141097-64308600 Smad6  
chr9 chr9:65885235-66085293 Zfp609  
chr9 chr9:69954918-70058009 Foxb1  
chr9 chr9:70611922-70725763 Cyclin B2  
chr9 chr9:72929790-73116983 Nedd4  
chr9 chr9:75145574-75273070 ONECUT1  
chr9 chr9:76060578-76283573 Bmp5  
chr9 chr9:106045068-106145068 miR135a1  
chr9 chr9:110068086-110282805 BAF155  
chr9 chr9:110893759-111000223 Tdgf1  
chr9 chr9:118398496-118505650 Eomes  
chr9 chr9:120878941-121005960 beta-catenin  
chr9 chr9:122880595-122988536 Zfp105  
chr10 chr10:19005947-19108012 Olig3  
chr10 chr10:21668568-21773755 Sgk  
chr10 chr10:42419342-42541008 Nr2e1  
chr10 chr10:44308196-44429651 Blimp1  
chr10 chr10:61128850-61236076 Nodal  
chr10 chr10:62298001-62418147 Ddx21  
chr10 chr10:63033272-63153303 SIRT1  
chr10 chr10:66933001-67110421 Jmjd1c Nrbf2 
chr10 chr10:69058799-69170623 Cdc2a  




chr10 chr10:79777175-79914231 Arid3a Wdr18 
chr10 chr10:82357052-82471278 Nfyb  
chr10 chr10:87189599-87290827 Ascl1  
chr10 chr10:88372950-88480841 Spic  
chr10 chr10:91789944-91889944 miR135a2  
chr10 chr10:95110933-95238734 Socs2  
chr10 chr10:102665136-102786170 Cart1  
chr10 chr10:107106895-107209915 Myf5  
chr10 chr10:107961900-108143330 Pawr  
chr10 chr10:120001945-120217367 Hmga2  
chr10 chr10:128136462-128254518 Tebp-pending  
chr10 chr10:128314825-128429698 Timeless  
chr11 chr11:4783546-4892852 NFH  
chr11 chr11:4914689-5043865 EWS  
chr11 chr11:7053174-7158624 Igfbp3  
chr11 chr11:18726000-18964236 Meis1  
chr11 chr11:20047172-20172425 Rab1  
chr11 chr11:21840346-21947131 Otx1  
chr11 chr11:35413368-35513368 miR103-1  
chr11 chr11:46198188-46318996 Dppa1  
chr11 chr11:51842343-51972310 Tcf7  
chr11 chr11:57391240-57494674 Hand1  
chr11 chr11:68961076-69076231 Jmjd3  
chr11 chr11:69142944-69319177 Trp53 Sox15 
chr11 chr11:72003925-72114105 Mybbp1a  
chr11 chr11:75026318-75126318 miR22  
chr11 chr11:86135778-86235778 miR21  
chr11 chr11:87037951-87207487 Tex14  
chr11 chr11:88620603-88741416 Trim25  
chr11 chr11:94761574-94866604 Dlx4  
chr11 chr11:95583855-95833085 Igf2bp1 Ndp52 
chr11 chr11:95901890-96083789 whole Hoxb  
chr11 chr11:98662388-98773764 Igfbp4  
chr11 chr11:100509359-100660510 Stat3  
chr11 chr11:101110890-101272966 Brca1  
chr11 chr11:101390874-101615477 Etv4 Meox1 
chr11 chr11:102508519-102618161 Gfap  
chr11 chr11:106276006-106436276 Pecam  
chr11 chr11:112403353-112508878 Sox9  
chr11 chr11:117587215-117690291 Socs3  
chr11 chr11:120767272-120869440 Tex19  
chr12 chr12:3650324-3827880 Dnmt3a  
chr12 chr12:13010106-13113542 Nmyc1  
chr12 chr12:20007157-20109424 Id2  




chr12 chr12:48528098-49342163 Npas3  
chr12 chr12:51674690-51779635 Titf1  
chr12 chr12:68328216-68441676 Six4  
chr12 chr12:80748307-80851673 Fos  
chr12 chr12:81636141-81899428 Esrrb  
chr12 chr12:99133736-99235763 Gsc  
chr12 chr12:99879273-99985226 Tcl1  
chr12 chr12:103496666-103620182 YY1  
chr12 chr12:104245775-104389564 Gtl2 miR127, 136, 337 
chr12 chr12:106368657-106471567 Ckb  
chr13 chr13:5600424-5706588 Klf6  
chr13 chr13:14769517-15133250 Gli3  
chr13 chr13:26423894-26529931 Prl3d1  
chr13 chr13:28278726-28383380 Sox4  
chr13 chr13:29239454-29415745 E2F3  
chr13 chr13:35046542-35360566 Cdyl  
chr13 chr13:40109182-40223950 Tcfap2a  
chr13 chr13:44145406-44434990 Jarid2  
chr13 chr13:46487908-46628938 AOF1  
chr13 chr13:47707354-47809960 Id4  
chr13 chr13:50177175-50277608 Histone H2A  
chr13 chr13:55301697-55403361 Neurog1  
chr13 chr13:55758625-55897352 Smad5  
chr13 chr13:74738340-74847658 Nr2f1  
chr13 chr13:80319428-80419428 miR9-2  
chr13 chr13:91552374-91660422 Otp  
chr13 chr13:109488347-109642277 Ddx4  
chr13 chr13:113208357-113318783 Isl1  
chr14 chr14:22986942-23088903 Hesx1  
chr14 chr14:30407535-30557024 Bmpr1a  
chr14 chr14:30668726-30840915 Wapl  
chr14 chr14:38995072-39097484 Bmp4  
chr14 chr14:39419546-39533567 Gmfb  
chr14 chr14:41281847-41391167 Otx2  
chr14 chr14:43433573-43537614 Mm.343880  
chr14 chr14:44696329-44810617 Zfp219  
chr14 chr14:46292529-46440620 Slc7a7  
chr14 chr14:48330736-48491472 Rnf17  
chr14 chr14:48847550-48994916 Zfp198  
chr14 chr14:55137504-55283853 Gata4  
chr14 chr14:55882889-55989917 Sox7  
chr14 chr14:56527472-56627472 miR124a1  
chr14 chr14:62098884-62255498 Piwil2  
chr14 chr14:89907436-90390711 Dach1  




chr14 chr14:114762314-114866705 Zic2  
chr15 chr15:10420640-10668160 Rai14  
chr15 chr15:37241795-37474132 Tcfcp2l3  
chr15 chr15:38322369-38428606 Klf10  
chr15 chr15:62150297-62255314 Myc  
chr15 chr15:76944649-77046213 FoxH1  
chr15 chr15:80170049-80310237 Cbx7  
chr15 chr15:93650232-93802057 Yaf2  
chr15 chr15:100639511-100772685 Atf1  
chr15 chr15:102837955-102964000 Sp1  
chr15 chr15:103351435-103573764 whole Hoxc  
chr16 chr16:15349099-15462234 Mcm4  
chr16 chr16:22029998-22150096 Sfrs10  
chr16 chr16:22164205-22322399 Etv5  
chr16 chr16:24625200-24725200 miR28  
chr16 chr16:48137444-48273389 Dppa4 Dppa2 
chr16 chr16:85287109-85606017 App  
chr16 chr16:91609775-91756171 Oligo2 Oligo1 
chr16 chr16:96375440-96493458 Ets2  
chr17 chr17:7792410-7900483 brachyury  
chr17 chr17:12037798-12288727 Igf2r/Air  
chr17 chr17:22145756-22327344 Zn206 Cldn6 
chr17 chr17:23216411-23328674 Zfp598  
chr17 chr17:25376258-25479203 Nkx2.5  
chr17 chr17:27649155-27750510 p21  
chr17 chr17:30671414-30818280 Notch3  
chr17 chr17:33689346-33801186 Bat1a  
chr17 chr17:33965652-34076734 Pou5f1 Tcf19 
chr17 chr17:35475987-35583584 Zfp57  
chr17 chr17:45708714-45814812 Cyclin D3  
chr17 chr17:48408531-48522729 Dazl  
chr17 chr17:54471290-54731109 miR7b Jmjd2b 
chr17 chr17:69223035-69330557 Tgif  
chr17 chr17:86221544-86373483 Msh2  
chr18 chr18:11226033-11357301 Gata6  
chr18 chr18:16909144-17228997 Cdh2  
chr18 chr18:21017614-21126518 Ttr  
chr18 chr18:35214792-35328913 Jmjd1b  
chr18 chr18:35508924-35744775 Catna1  
chr18 chr18:69819951-70259952 Tcf4  
chr18 chr18:71046188-71204011 Mbd2  
chr18 chr18:74115634-74280361 Smad4  
chr18 chr18:75848753-75977151 Smad7  
chr18 chr18:76302444-76888598 Zbtb36 Smad2 




chr18 chr18:85397012-85543379 Fbox15  
chr19 chr19:5376638-5487037 RelA  
chr19 chr19:6932089-7038651 coREST  
chr19 chr19:13676671-13924397 Tle4  
chr19 chr19:18165595-18323312 Rorb  
chr19 chr19:22364224-22488426 Klf9  
chr19 chr19:24730514-24929136 Dmrt1  
chr19 chr19:38107560-38244847 Hells  
chr19 chr19:42899051-43002549 Nkx2.3  
chr19 chr19:44523008-44625453 Lbx1  
chr19 chr19:56164644-56307162 Tdrd1  
chrX chrX:5877689-5992230 Syp  
chrX chrX:6198239-6306794 Gata1  
chrX chrX:29801083-29905847 Ehox  
chrX chrX:45462380-45595902 Hprt  
chrX chrX:49633109-49738369 Zic3  
chrX chrX:52408425-52509552 Sox3  
chrX chrX:64495744-64639927 Zfp185  
chrX chrX:65535214-65693977 MeCP2  
chrX chrX:77692687-77796846 Nr0b1  
chrX chrX:85576160-85724643 Zfx  
chrX chrX:92783268-92902166 Nono  
chrX chrX:93601021-93705348 Cited1  
chrX chrX:94765470-94929759 Xist/Tsix  
chrX chrX:126171135-126272600 Rex3  
chrX chrX:127072559-127177333 Esx1  
chrX chrX:142070723-142211219 Jarid1c  
chrUn_random chrUn_random:86135778- miR290-295  
chrUn_random chrUn_random:95380040- Obox5, Obox2  
    
    
    
    
    
    
    
    
 
 
